<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Atypon//DTD Atypon Systems Journal Archiving and Interchange NLM DTD v3.0.6 20130326//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName atypon-archivearticle3.dtd?><?SourceDTD.Version 3.0.6?><?ConverterInfo.XSLTName atyponoasis-oasisns2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Microb Drug Resist</journal-id><journal-id journal-id-type="iso-abbrev">Microb. Drug Resist</journal-id><journal-id journal-id-type="publisher-id">mdr</journal-id><journal-title-group><journal-title>Microbial Drug Resistance</journal-title></journal-title-group><issn pub-type="ppub">1076-6294</issn><issn pub-type="epub">1931-8448</issn><publisher><publisher-name>Mary Ann Liebert, Inc.</publisher-name><publisher-loc>140 Huguenot Street, 3rd FloorNew Rochelle, NY 10801USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5036315</article-id><article-id pub-id-type="pmid">27420548</article-id><article-id pub-id-type="publisher-id">10.1089/mdr.2016.0128</article-id><article-id pub-id-type="doi">10.1089/mdr.2016.0128</article-id><article-categories><subj-group subj-group-type="heading"><subject>Great Wall Symposium</subject></subj-group></article-categories><title-group><article-title>The VanRS Homologous Two-Component System VnlRS<sub>Ab</sub> of the Glycopeptide Producer <italic>Amycolatopsis balhimycina</italic> Activates Transcription of the <italic>vanHAX<sub>Sc</sub></italic> Genes in <italic>Streptomyces coelicolor</italic>, but not in <italic>A. balhimycina</italic></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kilian</surname><given-names>Regina</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Frasch</surname><given-names>Hans-Joerg</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kulik</surname><given-names>Andreas</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Wohlleben</surname><given-names>Wolfgang</given-names></name><xref ref-type="aff" rid="aff1"><sup>1,</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Stegmann</surname><given-names>Evi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1,</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><aff id="aff1"><label><sup>1</sup></label>Interfaculty Institute of Microbiology and Infection Medicine Tuebingen, Microbiology/Biotechnology, <institution>University of Tuebingen</institution>, Tuebingen, <country>Germany</country>.</aff><aff id="aff2"><label><sup>2</sup></label><institution>German Centre for Infection Research (DZIF)</institution>, Partner Site Tuebingen, Tuebingen, <country>Germany</country>.</aff></contrib-group><author-notes><corresp><addr-line>Address correspondence to:</addr-line><addr-line><italic>Evi Stegmann, PhD</italic></addr-line><addr-line><italic>Interfaculty Institute of Microbiology and Infection Medicine Tuebingen</italic></addr-line><addr-line><italic>Microbiology/Biotechnology</italic></addr-line><institution><italic>University of Tuebingen</italic></institution><addr-line><italic>Auf der Morgenstelle 28</italic></addr-line><addr-line><italic>72076 Tuebingen</italic></addr-line><country>Germany</country><break/><italic>E-mail:</italic><email xlink:href="mailto:evi.stegmann@biotech.uni-tuebingen.de">evi.stegmann@biotech.uni-tuebingen.de</email></corresp></author-notes><pub-date pub-type="ppub"><day>01</day><month>9</month><year>2016</year><!--string-date: September 2016--></pub-date><pub-date pub-type="epub"><day>01</day><month>9</month><year>2016</year></pub-date><pub-date pub-type="pmc-release"><day>01</day><month>9</month><year>2016</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>22</volume><issue>6</issue><fpage>499</fpage><lpage>509</lpage><permissions><copyright-statement>&#x000a9; Regina Kilian, et al., 2016; Published by Mary Ann Liebert, Inc.</copyright-statement><copyright-year>2016</copyright-year><license license-type="open-access"><license-p>This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="mdr.2016.0128.pdf"/><abstract><p>In enterococci and in <italic>Streptomyces coelicolor</italic>, a glycopeptide nonproducer, the glycopeptide resistance genes <italic>vanHAX</italic> are colocalized with <italic>vanRS</italic>. The two-component system (TCS) VanRS activates <italic>vanHAX</italic> transcription upon sensing the presence of glycopeptides. <italic>Amycolatopsis balhimycina</italic>, the producer of the vancomycin-like glycopeptide balhimycin, also possesses <italic>vanHAX<sub>Ab</sub></italic> genes. The genes for the VanRS-like TCS VnlRS<sub>Ab</sub>, together with the carboxypeptidase gene <italic>vanY<sub>Ab</sub></italic>, are part of the balhimycin biosynthetic gene cluster, which is located 2 Mb separate from the <italic>vanHAX<sub>Ab</sub></italic>. The deletion of <italic>vnlRS<sub>Ab</sub></italic> did not affect glycopeptide resistance or balhimycin production. In the <italic>A. balhimycina vnlR<sub>A</sub></italic><sub>b</sub> deletion mutant, the <italic>vanHAX<sub>Ab</sub></italic> genes were expressed at the same level as in the wild type, and peptidoglycan (PG) analyses proved the synthesis of resistant PG precursors. Whereas <italic>vanHAX<sub>Ab</sub></italic> expression in <italic>A. balhimycina</italic> does not depend on VnlR<sub>Ab</sub>, a VnlR<sub>Ab</sub>-depending regulation of <italic>vanY<sub>Ab</sub></italic> was demonstrated by reverse transcriptase polymerase chain reaction (RT-PCR) and RNA-seq analyses. Although VnlR<sub>Ab</sub> does not regulate the <italic>vanHAX<sub>Ab</sub></italic> genes in <italic>A. balhimycina</italic>, its heterologous expression in the glycopeptide-sensitive <italic>S. coelicolor</italic> &#x00394;<italic>vanRS<sub>Sc</sub></italic> deletion mutant restored glycopeptide resistance. VnlR<sub>Ab</sub> activates the <italic>vanHAX<sub>Sc</sub></italic> genes even in the absence of VanS. In addition, expression of <italic>vnlR<sub>Ab</sub></italic> increases actinorhodin production and influences morphological differentiation in <italic>S. coelicolor</italic>.</p></abstract><counts><fig-count count="6"/><table-count count="2"/><ref-count count="48"/><page-count count="11"/></counts></article-meta></front><body><sec sec-type="intro" id="s001"><title>Introduction</title><p>B<sc>acteria need to</sc> respond to changes in their environment. Therefore, they require adequate means to gain and process information on the immediate surroundings. Such means are represented by two-component systems (TCSs), which are ubiquitous in all prokaryotes. A typical TCS consists of a sensor histidine kinase (HK) and a response regulator (RR).<sup><xref rid="B1" ref-type="bibr">1</xref></sup> The HK measures a specific external signal and autophosphorylates at a conserved histidine residue within the cytosol. This phosphoryl group is transferred to the associated RR. The activated RR initiates the cellular response.<sup><xref rid="B2" ref-type="bibr">2</xref></sup> Most RRs are transcription factors that not only change the gene expression pattern of one or more genes of the cell, but also post-transcriptional and post-translational regulation of RNAs and proteins, respectively, by RRs has been reported.<sup><xref rid="B3" ref-type="bibr">3</xref></sup> The ability of bacteria to sense the signal enables them to react with an adaptive response.</p><p>Of special interest is the glycopeptide-sensing TCS VanRS that controls the expression of glycopeptide resistance genes in gram-positive pathogens,<sup><xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B5" ref-type="bibr">5</xref></sup> some glycopeptide producers, and other actinomycetes.<sup><xref rid="B6" ref-type="bibr">6</xref></sup> VanS is a membrane-standing HK. Its C-terminus extends into the cytoplasm and contains the kinase domain and the phosphorylation site.<sup><xref rid="B7" ref-type="bibr">7</xref></sup> VanS senses the presence of glycopeptides and catalyses adenosine triphosphate-dependent autophosphorylation of a specific histidine residue. Subsequently, VanS transfers the phosphate group to an aspartate residue of VanR, which then activates the transcription of the resistance genes. However, under noninduction conditions, VanS acts as a phosphatase, removing the phosphate group from VanR.<sup><xref rid="B8" ref-type="bibr">8</xref></sup></p><p>Glycopeptides such as vancomycin, teicoplanin, and telavancin are used for treating infections caused by gram-positive pathogens. They act by binding to the <italic>N-</italic>acyl-<sc>d</sc>-alanyl-<sc>d</sc>-alanine (<sc>d</sc>-Ala-<sc>d</sc>-Ala) termini of peptidoglycan (PG) and its precursor lipid II. This binding effectively sequesters the substrate for the transglycosylases and the <sc>d</sc>,<sc>d</sc>-transpeptidases, two key enzymes of cell wall synthesis, resulting in an inability to grow and subsequently to cell death.</p><p>Glycopeptide resistance is mediated by reprogramming cell wall biosynthesis. Ten types of resistances have been characterized so far (VanA-N).<sup><xref rid="B9" ref-type="bibr">9</xref>,<xref rid="B10" ref-type="bibr">10</xref></sup> In each case, the terminal <sc>d</sc>-alanine (<sc>d</sc>-Ala) in the pentapeptide side chain of the PG of gram-positive bacteria is substituted either by a <sc>d</sc>-lactate (<sc>d</sc>-Lac) (VanA, B, D, F, and M) or a <sc>d</sc>-serine (VanC, E, G, L and VanN). These substitutions result in a 1000-fold<sup><xref rid="B11" ref-type="bibr">11</xref></sup> or 6-fold<sup><xref rid="B12" ref-type="bibr">12</xref></sup> decreased binding affinity of the glycopeptide to its target, respectively. Categorization into the different phenotypes is based on the inducibility, the breadth of resistance to individual compounds, and the level of resistance.<sup><xref rid="B9" ref-type="bibr">9</xref></sup></p><p>Three of those phenotypes, VanC,<sup><xref rid="B13" ref-type="bibr">13</xref></sup> VanD,<sup><xref rid="B14" ref-type="bibr">14</xref></sup> and VanN,<sup><xref rid="B15" ref-type="bibr">15</xref>,<xref rid="B16" ref-type="bibr">16</xref></sup> are constitutively expressed. All others are inducible to different degrees by different glycopeptides. It was shown that enterococcus and staphylococcus strains expressing glycopeptide resistance genes constitutively are impaired in growth in comparison with strains where the genes are inducible.<sup><xref rid="B17" ref-type="bibr">17</xref>,<xref rid="B18" ref-type="bibr">18</xref></sup> Apparently, careful control of the expression of these genes is advantageous.</p><p><italic>Streptomyces coelicolor</italic> A3(2) is neither a pathogen nor a glycopeptide producer, but it is likely to encounter glycopeptides in its natural habitat. Therefore, it benefits from carrying <italic>vanRS<sub>Sc</sub></italic>, <italic>vanHAX<sub>Sc</sub></italic>, <italic>vanK<sub>Sc</sub></italic>, and <italic>vanJ<sub>Sc</sub></italic> (<xref ref-type="fig" rid="f1">Fig. 1C</xref>). VanH<sub>Sc</sub> is a <sc>d</sc>-stereospecific lactate dehydrogenase that converts pyruvate to <sc>d</sc>-Lac. VanA<sub>Sc</sub> is a <sc>d</sc>-Ala-<sc>d</sc>-Ala-ligase family protein that ligates <sc>d</sc>-Ala and <sc>d</sc>-Lac to <sc>d</sc>-Ala-<sc>d</sc>-Lac-depsipeptides. VanX<sub>Sc</sub> is a highly selective carboxypeptidase that cleaves the remaining <sc>d</sc>-Ala-<sc>d</sc>-Ala-dipeptide. VanK<sub>Sc</sub> belongs to the Fem family of enzymes, which add the cross-bridging amino acid(s) to the stem pentapeptide of PG precursors.<sup><xref rid="B19" ref-type="bibr">19</xref></sup> VanY is a membrane protein conferring resistance to teicoplanin. To identify the precise nature of the ligand signal that activates glycopeptide resistance in <italic>S. coelicolor</italic> A3(2), the VanB-type HK VanS<sub>Sc</sub>, sensing vancomycin, but not teicoplanin, was investigated.<sup><xref rid="B21" ref-type="bibr">21</xref>,<xref rid="B22" ref-type="bibr">22</xref></sup> Investigation on VanS<sub>Sc</sub> revealed opposed results. On the one hand, it was shown by cross-linking experiments that vancomycin is the direct ligand of the VanS<sub>Sc</sub>.<sup><xref rid="B21" ref-type="bibr">21</xref></sup> On the other hand, Kwun <italic>et al.</italic><sup><xref rid="B22" ref-type="bibr">22</xref></sup> demonstrated that VanS<sub>Sc</sub> is activated by vancomycin in complex with the <sc>d</sc>-Ala-<sc>d</sc>-Ala termini of PG precursors.</p><fig id="f1" fig-type="figure" orientation="portrait" position="float"><label><bold>FIG. 1.</bold></label><caption><p><bold>(A, B)</bold> EMBOSS stretcher pairwise sequence alignment of VnlRS<sub>Ab</sub> and VanRS<sub>Sc</sub>. <bold>(A)</bold> EMBOSS stretcher pairwise sequence alignment of VnlS<sub>Ab</sub> and VanS<sub>Sc</sub>. Transmembrane domains are indicated in <italic>blue</italic>. The extracytosolic domain is highlighted by a <italic>red box</italic>. <bold>(B)</bold> EMBOSS stretcher pairwise sequence alignment of VnlR<sub>Ab</sub> and VanR<sub>Sc</sub>. The site of aspartate phosphorylation is indicated by <italic>red</italic> and that of the proposed autophosphorylation by <italic>green arrow</italic>. <bold>(C)</bold> Organization of the resistance genes in <italic>Streptomyces coelicolor</italic> compared with that of <italic>Amycolatopsis balhimycina.</italic> &#x0201c;-&#x0201d; for a mismatch or a gap; &#x0201c;.&#x0201d; for any small positive score; &#x0201c;:&#x0201d; for a similarity, which scores more than 1.0; and &#x0201c;I&#x0201d; for an identity where both sequences have the same residue.</p></caption><graphic xlink:href="fig-1"/></fig><p>The actinomycete <italic>Amycolatopsis balhimycina</italic> produces the glycopeptide balhimycin, a vancomycin-type glycopeptide differing from vancomycin only in the glycosylation pattern.<sup><xref rid="B23" ref-type="bibr">23</xref>,<xref rid="B24" ref-type="bibr">24</xref></sup> The balhimycin biosynthesis gene cluster contains all genes necessary for balhimycin production<sup><xref rid="B25" ref-type="bibr">25</xref></sup> as well the <italic>vanRS-like</italic> regulatory genes, <italic>vnlRS<sub>Ab</sub></italic> and the accessory resistance gene <italic>vanY<sub>Ab</sub></italic> (<xref ref-type="fig" rid="f1">Fig. 1C</xref>).<sup><xref rid="B26" ref-type="bibr">26</xref></sup> VanYAb is a carboxypeptidase which cleaves the endstanding D-Ala-D-Ala-dipeptide from the PG precursors.<sup><xref rid="B27" ref-type="bibr">27</xref></sup> However, the <italic>vanHAX<sub>Ab</sub></italic> genes are encoded more than 2 Mb apart from the balhimycin biosynthesis cluster. Although VnlR<sub>Ab</sub> does not regulate glycopeptide resistance in <italic>A. balhimycina</italic>,<sup><xref rid="B27" ref-type="bibr">27</xref></sup> its heterologous expression in the glycopeptide-sensitive <italic>S. coelicolor</italic> strain M600 J2301<sup><xref rid="B6" ref-type="bibr">6</xref></sup> (&#x00394;<italic>vanRS<sub>Sc</sub></italic>) revealed unexpected effects. VnlR<sub>Ab</sub> activates the <italic>vanHAX<sub>Sc</sub></italic> genes, increases actinorhodin production, and influences morphological differentiation in <italic>S. coelicolor</italic>.</p></sec><sec sec-type="materials|methods" id="s002"><title>Materials and Methods</title><sec id="s003"><title>Bacterial, strains, plasmids, and primers</title><p>The strains and plasmids used for this study are listed in <xref ref-type="table" rid="T1">Table 1</xref>, the primers used for this study are listed in <xref ref-type="table" rid="T2">Table 2</xref>.</p><table-wrap id="T1" orientation="portrait" position="float"><label><sc>Table</sc> 1.</label><caption><p><sc>Bacterial Strains Used in This Study</sc></p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col align="left"/><col align="left"/><col align="left"/></colgroup><thead><tr><th align="left">&#x000a0;</th><th align="center"><italic>Relevant feature(s)</italic></th><th align="center"><italic>References</italic></th></tr></thead><tbody><tr><td colspan="3" align="left">Strains</td></tr><tr><td colspan="3" align="left">&#x02003;<italic>Streptomyces coelicolor</italic> A3(2)</td></tr><tr><td align="left">&#x02003;&#x02003;M600</td><td align="left">SCP1<sup>-</sup> SCP2<sup>-</sup></td><td align="center"><sup><xref ref-type="bibr" rid="B30">30</xref></sup></td></tr><tr><td align="left">&#x02003;&#x02003;M600 &#x00394;<italic>vanRS<sub>Sc</sub></italic> (J2301)</td><td align="left"><italic>vanRS<sub>Sc</sub></italic> deletion mutant</td><td align="center"><sup><xref ref-type="bibr" rid="B6">6</xref></sup></td></tr><tr><td align="left">&#x02003;&#x02003;M600 &#x00394;<italic>vanRS<sub>Sc</sub></italic> [<italic>vnlRS<sub>Ab</sub></italic>]</td><td align="left">&#x00394;<italic>vanRS<sub>Sc</sub></italic> complemented with pRM4<italic>vnlRS<sub>Ab</sub></italic></td><td align="center">This study</td></tr><tr><td align="left">&#x02003;&#x02003;M600 &#x00394;<italic>vanRS<sub>Sc</sub></italic> [<italic>vnlR<sub>Ab</sub></italic>]</td><td align="left">&#x00394;<italic>vanRS<sub>Sc</sub></italic> complemented with pRM4<italic>vnlR<sub>Ab</sub></italic></td><td align="center">This study</td></tr><tr><td align="left">&#x02003;&#x02003;M600 &#x00394;<italic>vanRS<sub>Sc</sub></italic> [<italic>vnlS<sub>Ab</sub></italic>]</td><td align="left">&#x00394;<italic>vanRS<sub>Sc</sub></italic> complemented with pRM4<italic>vnlS<sub>Ab</sub></italic></td><td align="center">This study</td></tr><tr><td align="left">&#x02003;&#x02003;M600 &#x00394;<italic>vanRS<sub>Sc</sub></italic> [<italic>vnlR<sub>Ab</sub></italic>D51A]</td><td align="left">&#x00394;<italic>vanRS<sub>Sc</sub></italic> complemented with pRM4<italic>vnlR<sub>Ab</sub></italic>D51A</td><td align="center">This study</td></tr><tr><td colspan="3" align="left">&#x02003;<italic>Amycolatopsis balhimycina</italic> DSM 5908</td></tr><tr><td align="left">&#x02003;&#x02003;<italic>A. balhimycina</italic> WT DSM 5908</td><td align="left">Wildtype</td><td align="center"><sup><xref ref-type="bibr" rid="B24">24</xref></sup></td></tr><tr><td align="left">&#x02003;&#x02003;<italic>A. balhimycina</italic> &#x00394;<italic>vnlR<sub>Ab</sub></italic></td><td align="left"><italic>vnlR<sub>Ab</sub></italic> deletion mutant</td><td align="center"><sup><xref ref-type="bibr" rid="B27">27</xref></sup></td></tr><tr><td align="left">&#x02003;&#x02003;<italic>A. balhimycina</italic> [<italic>vnlR<sub>Ab</sub></italic>]</td><td align="left">Overexpression of <italic>vnlR<sub>Ab</sub></italic> in <italic>A. balhimycina</italic>, using pRM4<italic>vnlR<sub>Ab</sub></italic></td><td align="center">This study</td></tr><tr><td align="left">&#x02003;&#x02003;<italic>A. balhimycina</italic> &#x00394;<italic>vnlR<sub>Ab</sub></italic> [<italic>vnlR<sub>Ab</sub></italic>]</td><td align="left">&#x00394;<italic>vnlR<sub>Ab</sub></italic> complemented with pRM4vnlR<sub>Ab</sub></td><td align="center">This study</td></tr><tr><td align="left">&#x02003;&#x02003;<italic>A. balhimycina</italic> &#x00394;<italic>vnlS<sub>Ab</sub></italic></td><td align="left"><italic>vnlS<sub>Ab</sub></italic> deletion mutant</td><td align="center">This study</td></tr><tr><td colspan="3" align="left">&#x02003;<italic>Escherichia coli</italic></td></tr><tr><td align="left">&#x02003;&#x02003;XL1-blue</td><td align="left"><italic>recA1; endA1; gyrA96; tji-1; hsdR17; supE44; relA1; lac</italic> [F'<italic>proAB, lac</italic><sup>q</sup>Z&#x00394;M15Tn<italic>10</italic>(<italic>tet<sup>r</sup></italic>)]</td><td align="center"><sup><xref ref-type="bibr" rid="B28">28</xref></sup></td></tr><tr><td align="left">&#x02003;&#x02003;ET 12567 pUZ8002</td><td align="left">pUZ8002; <italic>kan<sup>r</sup></italic></td><td align="center"><sup><xref ref-type="bibr" rid="B34">34</xref></sup></td></tr><tr><td align="left">&#x02003;&#x02003;ET 12567</td><td align="left">F<sup>-</sup>; <italic>dam13::</italic>Tn<italic>9; dcm-6; hsdM; hsdR; recF143; zjj201::</italic>Tn<italic>10</italic>; <italic>galK2; galT22; ara14; lacY1; xyl15; leuB6; thi1; tonA31; rpsL136; hisG4; tsx78; mtli; glnV44</italic></td><td align="center"><sup><xref ref-type="bibr" rid="B29">29</xref></sup></td></tr><tr><td colspan="3" align="left">Plasmids</td></tr><tr><td align="left">&#x02003;pRM4</td><td align="left">pSET152 <italic>ermE</italic>p<sup>*</sup>, RBS, &#x003a6;31 <italic>attP-int-</italic>derived integration vector</td><td align="center"><sup><xref ref-type="bibr" rid="B31">31</xref></sup></td></tr><tr><td align="left">&#x02003;pRM4vnlRS<sub>Ab</sub></td><td align="left">Expression plasmid for <italic>vnlRS<sub>Ab</sub></italic></td><td align="center">This study</td></tr><tr><td align="left">&#x02003;pRM4vnlR<sub>Ab</sub></td><td align="left">Expression plasmid for <italic>vnlR<sub>Ab</sub></italic></td><td align="center">This study</td></tr><tr><td align="left">&#x02003;pRM4vnlS<sub>Ab</sub></td><td align="left">Expression plasmid for <italic>vnlS<sub>Ab</sub></italic></td><td align="center">This study</td></tr><tr><td align="left">&#x02003;pRM4vnlR<sub>Ab</sub>D51A</td><td align="left">Expression plasmid for <italic>vnlR<sub>Ab</sub></italic>,</td><td align="center">This study</td></tr><tr><td align="left">&#x000a0;</td><td align="left">Exchange of Asp at position 51 with Ala</td><td align="left">&#x000a0;</td></tr><tr><td align="left">&#x02003;pSP1</td><td align="left">Inactivation vector in <italic>A. balhimycina</italic></td><td align="center"><sup><xref ref-type="bibr" rid="B32">32</xref></sup></td></tr><tr><td align="left">&#x000a0;</td><td align="left">Erythromycin and ampicillin resistance</td><td align="left">&#x000a0;</td></tr><tr><td align="left">&#x02003;pSP&#x00394;vnlS<sub>Ab</sub></td><td align="left">pSP1 carrying a 1579&#x02009;bp upstream and a 1509&#x02009;bp downstream fragment of <italic>vnlS<sub>Ab</sub></italic></td><td align="center">This study</td></tr></tbody></table><table-wrap-foot><fn id="tf1"><p>WT, wild type.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T2" orientation="portrait" position="float"><label><sc>Table</sc> 2.</label><caption><p><sc>Primers Used in This Study</sc></p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/></colgroup><thead><tr><th align="left">&#x000a0;</th><th align="center"><italic>Primer</italic></th><th align="center"><italic>Sequence</italic></th><th align="center"><italic>Relevant feature(s)</italic></th><th align="center"><italic>References</italic></th></tr></thead><tbody><tr><td align="left">1</td><td align="left">vnlRS-compl.1</td><td align="left">CATCGG<bold>C</bold>ATATGCGCGTGCTGATCGTCGAG</td><td align="left">Cloning of <italic>vnlRS<sub>Ab</sub></italic></td><td align="left">This study</td></tr><tr><td align="left">2</td><td align="left">vnlRS-compl. 2</td><td align="left">GAATT<bold>C</bold>CTGCGCGACTCCAGCGTTTCTCAGCGGAAG</td><td align="left">&#x000a0;</td><td align="left">&#x000a0;</td></tr><tr><td align="left">3</td><td align="left">vnlR-over</td><td align="left">GAATT<bold>C</bold>AGGCGTAGCTGAGG</td><td align="left">Cloning of <italic>vnlR<sub>Ab</sub></italic></td><td align="left">This study</td></tr><tr><td align="left">4</td><td align="left">vnlS-cloning</td><td align="left">ATCATATGAGCGTCCGCCTCAAAC</td><td align="left">Cloning of <italic>vnlS<sub>Ab</sub></italic></td><td align="left">This study</td></tr><tr><td align="left">5</td><td align="left">vnlRD51A1</td><td align="left">GAATATCCCGGgCGAGGACGG</td><td align="left">Recombinant primers for aa exchange</td><td align="left">This study</td></tr><tr><td align="left">6</td><td align="left">vnlRD51A2</td><td align="left">CCGTCCTCGcCCGGGATATT</td><td align="left">&#x000a0;</td><td align="left">&#x000a0;</td></tr><tr><td align="left">7</td><td align="left">vnlSdelFrg1for</td><td align="left">TTAGAATTCGATTGTCCGCGAGAAATG</td><td align="left">Cloning of <italic>vnlS<sub>Ab</sub></italic> upstream region</td><td align="left">This study</td></tr><tr><td align="left">8</td><td align="left">vnlSdelFrg1rev</td><td align="left">TAATCTAGACCCGGCCGCTCTGTC</td><td align="left">&#x000a0;</td><td align="left">&#x000a0;</td></tr><tr><td align="left">9</td><td align="left">vnlSdelFrg2for</td><td align="left">TTATCTAGACCGGCCGGGTCACCTC</td><td align="left">Cloning of <italic>vnlS<sub>Ab</sub></italic> downstream region</td><td align="left">This study</td></tr><tr><td align="left">10</td><td align="left">vnlSdelFrg2rev</td><td align="left">ATTGCATGCGGGCGCAAGTGAGTTTCGGTCATCG</td><td align="left">&#x000a0;</td><td align="left">&#x000a0;</td></tr><tr><td align="left">11</td><td align="left">pSETerme rev</td><td align="left">ATGCTAGTCGCGGTTGA</td><td align="left">Integration of Plasmid and Insert</td><td align="left">This study</td></tr><tr><td align="left">12</td><td align="left">attBli-fwd</td><td align="left">TTCTGGAAATCCTCGAAGGC</td><td align="left">Integration of plasmid through &#x003a6;C31</td><td align="left">&#x000a0;</td></tr><tr><td align="left">13</td><td align="left">attPint-rev</td><td align="left">TGTGCATGCGCCCACGAATG</td><td align="left">&#x000a0;</td><td align="left">&#x000a0;</td></tr><tr><td align="left">14</td><td align="left">ery for</td><td align="left">AAGGGAGAAAGGCGGACAGG</td><td align="left">Proof of erythromycin resistance cassette</td><td align="left">This study</td></tr><tr><td align="left">15</td><td align="left">ery rev</td><td align="left">GTCGCTTCTGCGCAAGTACC</td><td align="left">&#x000a0;</td><td align="left">&#x000a0;</td></tr><tr><td align="left">16</td><td align="left"><italic>vnlS</italic>proof for</td><td align="left">TGCTCGAAGTCCTCGTTTCC</td><td align="left">Integration and deletion verification</td><td align="left">This study</td></tr><tr><td align="left">17</td><td align="left"><italic>vnlS</italic>proof rev</td><td align="left">GCAAGTACGTGAGCGATCAG</td><td align="left">&#x000a0;</td><td align="left">&#x000a0;</td></tr><tr><td align="left">18</td><td align="left">vanS<sub>Sc</sub>_RT_1</td><td align="left">CTCCAACTGACCACGAACCT</td><td align="left">RT-PCR analysis in <italic>S. coelicolor</italic> M600</td><td align="left">This study</td></tr><tr><td align="left">19</td><td align="left">vanS<sub>Sc</sub>_RT_2</td><td align="left">GGTCGGTGTGTATGCGTTC</td><td align="left">&#x000a0;</td><td align="left">&#x000a0;</td></tr><tr><td align="left">20</td><td align="left">vanR<sub>Sc</sub>_RT_1</td><td align="left">TGCTGAGTGTCAACGCCTAC</td><td align="left">&#x000a0;</td><td align="left">&#x000a0;</td></tr><tr><td align="left">21</td><td align="left">vanR<sub>Sc</sub>_RT_2</td><td align="left">CGAACTGCTTCCTGGTCAAC</td><td align="left">&#x000a0;</td><td align="left">&#x000a0;</td></tr><tr><td align="left">22</td><td align="left">vanA<sub>Sc</sub>_RT_1</td><td align="left">ACCGTGACAGGAGACGAGAC</td><td align="left">&#x000a0;</td><td align="left">&#x000a0;</td></tr><tr><td align="left">23</td><td align="left">vanA<sub>Sc</sub>_RT_2</td><td align="left">CTGGTGGATCCGGAAGAAT</td><td align="left">&#x000a0;</td><td align="left">&#x000a0;</td></tr><tr><td align="left">24</td><td align="left">hrdBSc_RT_1</td><td align="left">TGACCAGATTCCGGCCACTC</td><td align="left">&#x000a0;</td><td align="left">This study</td></tr><tr><td align="left">25</td><td align="left">hrdBSc_RT_2</td><td align="left">CTTCGCTGCGACGCTCTTTC</td><td align="left">&#x000a0;</td><td align="left">&#x000a0;</td></tr><tr><td align="left">26</td><td align="left">sigB for</td><td align="left">CGTAGGTCGAGAACTTGAAC</td><td align="left">RT-PCR analysis in <italic>A balhimycina</italic> DSM5908</td><td align="left"><sup><xref ref-type="bibr" rid="B41">41</xref></sup></td></tr><tr><td align="left">27</td><td align="left">sigB rev</td><td align="left">GTGTCTACCTCAACGGTATC</td><td align="left">&#x000a0;</td><td align="left">&#x000a0;</td></tr><tr><td align="left">28</td><td align="left">vanH1</td><td align="left">GGGACAAGCCCATCAAGAAC</td><td align="left">&#x000a0;</td><td align="left"><sup><xref ref-type="bibr" rid="B27">27</xref></sup></td></tr><tr><td align="left">29</td><td align="left">vanA2</td><td align="left">GAGCGGACTTGACGGAGATG</td><td align="left">&#x000a0;</td><td align="left">&#x000a0;</td></tr><tr><td align="left">30</td><td align="left"><italic>vanY</italic>_RT_fwd</td><td align="left">TCGGCACGAGGATTG</td><td align="left">&#x000a0;</td><td align="left">&#x000a0;</td></tr><tr><td align="left">31</td><td align="left"><italic>vanY</italic>_RT_rev</td><td align="left">TTCACGCACAGTTCG</td><td align="left">&#x000a0;</td><td align="left">&#x000a0;</td></tr></tbody></table><table-wrap-foot><fn id="tf2"><p>RT-PCR, reverse transcriptase polymerase chain reaction.</p></fn></table-wrap-foot></table-wrap><p><italic>Escherichia coli</italic> XL1-blue<sup><xref rid="B28" ref-type="bibr">28</xref></sup> was used for cloning purposes, and the methylation-deficient strain <italic>E. coli</italic> ET12567<sup><xref rid="B29" ref-type="bibr">29</xref></sup> was used to obtain unmethylated DNA for <italic>A. balhimycina</italic> transformations.</p><p><italic>A. balhimycina</italic><sup><xref rid="B24" ref-type="bibr">24</xref></sup> is the balhimycin-producing wild type (WT) and was used to generate the <italic>vnlS</italic> deletion as well as the <italic>vnlR</italic>-overexpressing strains (this study). Furthermore, &#x00394;<italic>vnlR</italic> deletion<sup><xref rid="B27" ref-type="bibr">27</xref></sup> was used for complementation (this study).</p><p><italic>S. coelicolor</italic> M600<sup><xref rid="B30" ref-type="bibr">30</xref></sup> were used to generate <italic>S. coelicolor</italic> M600 &#x00394;<italic>vanRS</italic>.<sup><xref rid="B6" ref-type="bibr">6</xref></sup> This deletion strain was used to generate complementations with <italic>vnlRS<sub>Ab</sub></italic>, <italic>vnlR<sub>Ab</sub></italic>, <italic>vnlS<sub>Ab</sub></italic>, and <italic>vnlR<sub>Ab</sub></italic>D51A (this study).</p><p>The overexpression plasmids pRM4vnlRS<sub>Ab</sub>, pRM4vnlR<sub>Ab</sub>, pRM4vnlS<sub>Ab</sub>, and pRM4vnlR<sub>Ab</sub>D51A are derived from pRM4<sup><xref rid="B31" ref-type="bibr">31</xref></sup>, a pSET152-derived nonreplicative, &#x003a6;C31 integration vector with an integrated constitutive <italic>ermEp</italic>* promoter, an artificial ribosomal binding site, and an apramycin resistance cassette.</p><p>The deletion vector pSP&#x00394;vnlS<sub>Ab</sub> is derived from pSP1<sup><xref rid="B32" ref-type="bibr">32</xref></sup> in which flanking regions of <italic>vnlS<sub>Ab</sub></italic> were cloned.</p></sec><sec id="s004"><title>Media and culture conditions</title><p><italic>A. balhimycina</italic> grown in 100&#x02009;ml TSB medium (Difco) for 48&#x02009;hr and 2&#x02009;ml of this preculture were used to inoculate the main cultures either in 100&#x02009;ml R5<sup><xref rid="B30" ref-type="bibr">30</xref></sup> or in TSB medium. R5 medium was used to stimulate balhimycin production, while TSB medium was used when balhimycin production should be prevented. After 48&#x02009;hr of cultivation, the mycelium was used to isolate PG precursors, to extract DNA, or to perform resistance assays against different glycopeptides. To isolate RNA, the cells were grown 15/39/63&#x02009;hr. Balhimycin production assays were performed after 5 days of growth.</p><p><italic>S. coelicolor</italic> M145 and M600 were grown on Cullum-agar plates for sporulation. Isolated spores were used to inoculate 10&#x02009;ml R5 medium as preculture for cell wall precursor extraction or DNA extraction. For RNA isolation, 2&#x02009;ml of a 48-hr-old TSB preculture was used to inoculate 100&#x02009;ml of HA medium. The cells were harvested after 69&#x02009;hr.</p><p>To compare the growth of the different <italic>S. coelicolor</italic> strains, 10&#x02009;&#x003bc;l spores (&#x0223c;1.5&#x02009;&#x000d7;&#x02009;10<sup>7</sup>) of each strain were streaked on a YM plate. The plate was incubated for 7 days.</p><p><italic>A. balhimycina</italic> and <italic>S. coelicolor</italic> were grown at 30&#x000b0;C, and liquid cultures were shaken at 180&#x02009;rpm.</p><p><italic>A. balhimycina</italic> and <italic>S. coelicolor</italic> strains were cultivated in 100&#x02009;ml of R5 medium in an orbital shaker (220&#x02009;rpm) in 500-ml baffled Erlenmeyer flasks at 27&#x000b0;C.</p><p>Liquid/solid media were supplemented with 100&#x02009;&#x003bc;g/ml apramycin to select for strains carrying integrated antibiotic resistance genes.</p><p><italic>E. coli</italic> was grown in Luria-Bertani broth (Roth) at 37&#x000b0;C using 100&#x02009;&#x003bc;g/&#x003bc;l apramycin or 150&#x02009;&#x003bc;g/&#x003bc;l ampicillin for selection of plasmid-containing colonies. Liquid cultures were shaken at 180&#x02009;rpm.</p></sec><sec id="s005"><title>Plasmid construction</title><p>For the heterologous expression in <italic>S. coelicolor</italic> &#x00394;<italic>vanRS<sub>Sc</sub></italic>, the entire coding regions of the <italic>vnlR<sub>Ab</sub></italic> (<xref ref-type="table" rid="T2">Table 2</xref> primer 1&#x02009;+&#x02009;3), <italic>vnlRS<sub>Ab</sub></italic> (<xref ref-type="table" rid="T2">Table 2</xref> primer 1&#x02009;+&#x02009;2), and <italic>vnlS<sub>Ab</sub></italic> (primer 4&#x02009;+&#x02009;2) were amplified using Kapa-Hifi proofreading polymerase and the corresponding primers in brackets.</p><p>The <italic>vnlR<sub>Ab</sub></italic> (758&#x02009;bp), <italic>vnlRS<sub>Ab</sub></italic> (1908&#x02009;bp), and <italic>vnlS<sub>Ab</sub></italic> (1198&#x02009;bp) polymerase chain reaction (PCR) products were integrated into pRM4<sup><xref rid="B31" ref-type="bibr">31</xref></sup> through the primer-attached restriction sites (Nde-EcoRI) downstream of the <italic>ermEp</italic>* promoter.</p><p>Site-directed mutagenesis by overlap extension<sup><xref rid="B33" ref-type="bibr">33</xref></sup> was performed for the exchange of aspartate at position 51 to an alanine with the primers 5&#x02009;+&#x02009;6 (<xref ref-type="table" rid="T2">Table 2</xref>). The 758&#x02009;bp PCR product <italic>vnlR<sub>Ab</sub></italic>D51A was integrated into pRM4 through the primer-attached restriction sites (Nde-EcoRI) downstream of the <italic>ermEp</italic>* promoter.</p><p>For the in-frame deletion of <italic>vnlS<sub>A</sub></italic><sub>b</sub> (1125&#x02009;bp), a 1579&#x02009;bp upstream fragment (<xref ref-type="table" rid="T2">Table 2</xref> primer 7&#x02009;+&#x02009;8) and a 1509&#x02009;bp downstream fragment (<xref ref-type="table" rid="T2">Table 2</xref> primer 9&#x02009;+&#x02009;10) of <italic>vnlS<sub>Ab</sub></italic> were amplified from <italic>A. balhimycina</italic> genomic DNA using Kapa-Hifi proofreading polymerase and the corresponding primers in brackets. The plasmid pSP&#x00394;vnlS was constructed by integration of the fragments in pSP1<sup><xref rid="B30" ref-type="bibr">30</xref></sup> through the primer-attached restriction sites at the 5&#x02032; and 3&#x02032; ends (EcoRI/XbaI and XbaI/SphI) (pSP&#x00394;vnlS).</p></sec><sec id="s006"><title>DNA transfer</title><p>Transformation of <italic>E. coli</italic> XL1-blue<sup><xref rid="B28" ref-type="bibr">28</xref></sup> and ET12567 (pUZ8002)<sup><xref rid="B34" ref-type="bibr">34</xref></sup> was performed as described previously.<sup><xref rid="B35" ref-type="bibr">35</xref>,<xref rid="B36" ref-type="bibr">36</xref></sup></p><p>Plasmids pRM4vnlRS<sub>Ab</sub>, pRM4vnlR<sub>Ab</sub>, pRM4vnlS<sub>Ab</sub>, and pRM4vnlR<sub>Ab</sub>D51A were transferred into <italic>S. coelicolor</italic> through intergeneric conjugation.<sup><xref rid="B30" ref-type="bibr">30</xref></sup> Plasmid integration was confirmed by colony PCR using the primer pair 12&#x02009;+&#x02009;13 (<xref ref-type="table" rid="T2">Table 2</xref>) or primer 11 (<xref ref-type="table" rid="T2">Table 2</xref>) in combination with a reverse primer of corresponding gene.</p><p>pRM4vnlR<sub>Ab</sub> and pRM4vnlR<sub>Ab</sub>D51A were transferred into <italic>A. balhimycina</italic> through the direct transformation method<sup><xref rid="B32" ref-type="bibr">32</xref>,<xref rid="B37" ref-type="bibr">37</xref></sup> using unmethylated plasmid DNA isolated from <italic>E. coli</italic> ET12567. Integration of plasmid was verified by PCR using primer pair 11&#x02009;+&#x02009;3 (<xref ref-type="table" rid="T2">Table 2</xref>).</p><p>For deletion of <italic>vnlS<sub>Ab</sub></italic>, <italic>A. balhimycina</italic> WT was transformed with pSP&#x00394;vnlS<sub>Ab</sub> by direct transformation. The integration of the plasmid into the chromosome through homologous recombination was confirmed by PCR screening for the erythromycin resistance cassette, using primers ery for and ery rev (<xref ref-type="table" rid="T2">Table 2</xref>). To obtain deletion mutants, a second homologous recombination event was provoked by stressing plasmid-carrying colonies as described by Puk <italic>et al</italic>.<sup><xref rid="B38" ref-type="bibr">38</xref></sup> Colonies were examined for sensitivity to erythromycin, and the deletions were verified by PCR analysis, using primers 16&#x02009;+&#x02009;17 (<xref ref-type="table" rid="T2">Table 2</xref>).</p></sec><sec id="s007"><title>Sequence alignment</title><p>The amino acid (AA) sequences of VnlRS<sub>Ab</sub>, VanR<sub>Sc</sub>, and VanS<sub>Sc</sub> are available under accession number Y16952 (named VanRS), (SCO3590), and (SCO3589), respectively.</p><p>Alignment of the AA sequences was performed by EMBOSS stretcher<sup><xref rid="B39" ref-type="bibr">39</xref></sup>; (<uri xlink:type="simple" xlink:href="http://www.ebi.ac.uk/Tools/psa/emboss_stretcher/">www.ebi.ac.uk/Tools/psa/emboss_stretcher/</uri>).</p></sec><sec id="s008"><title>Resistance test, reverse transcriptase polymerase chain reaction analyses, PG precursor, and cell wall analysis</title><p>Resistance test, reverse transcriptase polymerase chain reaction (RT-PCR) analyses, extraction of PG precursors, PG isolation, and the high-performance liquid chromatography&#x02013;mass spectrometry (HPLC-MS) analyses were performed as described.<sup><xref rid="B27" ref-type="bibr">27</xref>,<xref rid="B40" ref-type="bibr">40</xref></sup></p></sec><sec id="s009"><title>Balhimycin concentration</title><p>The balhimycin concentration in 1&#x02009;ml culture was quantified using HPLC with a photodiode array detector (HPLC-DAD) as described.<sup><xref rid="B40" ref-type="bibr">40</xref></sup> The balhimycin concentration was calculated to 100&#x02009;&#x003bc;g/ml total DNA.</p></sec><sec id="s010"><title>Inference of biomass concentration from DNA quantification</title><p>For the quantification of total DNA in 1&#x02009;ml culture, an acid extraction of DNA coupled with a colorimetric method<sup><xref rid="B41" ref-type="bibr">41</xref></sup> was performed by measuring the absorbance at 600&#x02009;nm. To analyze the amount of DNA, a standard curve with salmon sperm DNA was generated.</p></sec></sec><sec sec-type="results" id="s011"><title>Results</title><sec id="s012"><title><italic>A. balhimycina</italic> includes a VanRS homologous TCS (VnlRS<sub>Ab</sub>) encoded in the balhimycin biosynthetic gene cluster</title><p>In most of the antibiotic-producing bacteria, the antibiotic biosynthetic gene clusters include resistance genes. One exception is the balhimycin producer <italic>A. balhimycina</italic>. In this study, the glycopeptide resistance genes <italic>vanHAX<sub>Ab</sub></italic> are located 2 Mb apart from the balhimycin biosynthetic gene cluster. In addition, the resistance is characterized by another unusual feature: the counterpart of the well-known TCS VanRS, which is known to regulate <italic>vanHAX</italic> expression in pathogens and in <italic>S. coelicolor</italic> is encoded by genes (<italic>vnlRS<sub>Ab</sub></italic>), which are part of the biosynthetic gene cluster and are therefore not colocated with the <italic>vanHAX<sub>Ab</sub></italic> genes.</p><p>VanRS<sub>Sc</sub> of <italic>S. coelicolor</italic> was reported to sense glycopeptides and to activate the expression of the <italic>vanHAX<sub>Sc</sub></italic> genes.<sup><xref rid="B19" ref-type="bibr">19</xref></sup> To elucidate the differences of the two actinomycete TCSs, we compared the AA sequence of VnlRS<sub>Ab</sub> with the sequence of VanRS<sub>Sc</sub>. Sequence alignment using EMBOSS stretcher<sup><xref rid="B39" ref-type="bibr">39</xref></sup> revealed 82% sequence similarity between VnlR<sub>Ab</sub> and VanR<sub>Sc</sub> (Sco3590) and 73% between VnlS<sub>Ab</sub> and VanS<sub>Sc</sub> (Sco3589) (<xref ref-type="fig" rid="f1">Fig. 1A, B</xref>). Based on the high similarity, a corresponding function of both RRs could be proposed.</p><p>In <italic>S. coelicolor</italic>, VanS<sub>Sc</sub> phosphorylates VanR<sub>Sc</sub> at the aspartate at AA position 51. Replacement of this residue with an alanine completely destroyed the activity of VanR<sub>Sc</sub>.<sup><xref rid="B6" ref-type="bibr">6</xref></sup> It has been shown that in <italic>S. coelicolor</italic>, in the absence of vancomycin, acetylphosphate phosphorylates VanR<sub>Sc</sub>, whereas VanS<sub>Sc</sub> acts as a phosphatase to decrease the level of VanR<sub>Sc</sub>&#x0223c;P. On exposure to vancomycin, VanS activity switches from a phosphatase to a kinase and vancomycin resistance is induced.<sup><xref rid="B6" ref-type="bibr">6</xref></sup> Furthermore, Novotna <italic>et al.</italic><sup><xref rid="B42" ref-type="bibr">42</xref></sup> specified a serine residue at AA position 69 important for autophosphorylation through acetyl phosphate.</p><p>Sequence comparison revealed that VnlR<sub>Ab</sub> contains both, a conserved aspartate at AA position 51 (D51) and a serine at AA position 69, the position that probably becomes autophosphorylated through acetyl phosphate (<xref ref-type="fig" rid="f1">Fig. 1B</xref>), indicating an analogous phosphorylation pattern of VnlR<sub>Ab</sub> compared with VanR<sub>Sc</sub>.</p></sec><sec id="s013"><title>The RR VnlR<sub>Ab</sub> does not control expression of the <italic>vanHAX<sub>Ab</sub></italic> genes in <italic>A. balhimycina</italic></title><p>In <italic>A. balhimycina</italic>, <italic>vanHAX<sub>Ab</sub></italic> expression does not depend on VnlRS<sub>Ab</sub>. The deletion of <italic>vnlR<sub>Ab</sub></italic> had no effect on glycopeptide resistance and did not result in any obvious phenotype.<sup><xref rid="B27" ref-type="bibr">27</xref></sup> This raises the interesting question on the function of this TCS in <italic>A. balhimycina</italic>.</p><p>Since overexpression of RRs of two-component signal transduction systems often modulates multidrug resistance,<sup><xref rid="B43" ref-type="bibr">43</xref>,<xref rid="B44" ref-type="bibr">44</xref></sup> we overexpressed <italic>vnlR<sub>Ab</sub></italic> in <italic>A. balhimycina</italic> to analyze the effects on resistance and antibiotic production. <italic>vnlR<sub>Ab</sub></italic> was cloned under the control of the constitutive promoter <italic>ermE*p</italic> into the integrative plasmid pRM4 (pRM4vnlR<sub>Ab</sub>). pRM4vnlR<sub>Ab</sub> was transferred into <italic>A. balhimycina</italic> WT and into the <italic>A. balhimycina</italic> &#x00394;<italic>vnlR<sub>Ab</sub></italic> mutant,<sup><xref rid="B27" ref-type="bibr">27</xref></sup> resulting in the recombinant strains <italic>A. balhimycina</italic> [<italic>vnlR<sub>Ab</sub></italic>] and <italic>A. balhimycina</italic> &#x00394;<italic>vnlR<sub>Ab</sub></italic> [<italic>vnlR<sub>Ab</sub></italic>], respectively. The phenotypes of the recombinant strains overexpressing VnlR<sub>Ab</sub> and (as a control) that of the deletion mutant <italic>A. balhimycina</italic> &#x00394;<italic>vnlR<sub>Ab</sub></italic> were compared with the WT phenotype (<xref ref-type="fig" rid="f2">Fig. 2</xref>). All strains produced balhimycin at the same level (<xref ref-type="fig" rid="f2">Fig. 2A</xref>). No differences in resistance against balhimycin were observed. Using a method optimized for actinomycetes,<sup><xref rid="B27" ref-type="bibr">27</xref></sup> muropeptides from all <italic>A. balhimycina</italic> strains cultivated under balhimycin production conditions were isolated. HPLC/MS chromatograms showed the similar muropeptide composition pattern for all strains (<xref ref-type="fig" rid="f2">Fig. 2B</xref>).</p><fig id="f2" fig-type="figure" orientation="portrait" position="float"><label><bold>FIG. 2.</bold></label><caption><p>Analysis of balhimycin production, muropeptide composition, and PG precursors in <italic>A. balhimycina</italic> WT (1), <italic>A. balhimycina</italic> &#x00394;<italic>vnlR<sub>Ab</sub></italic> (2), <italic>A. balhimycina</italic> [<italic>vnlR<sub>Ab</sub></italic>] (3), and <italic>A. balhimycina</italic> &#x00394;<italic>vnlR<sub>Ab</sub></italic> [<italic>vnlR<sub>Ab</sub></italic>] (4). <bold>(A)</bold> Production of balhimycin measured by HPLC (<italic>n</italic>&#x02009;=&#x02009;5). <bold>(B)</bold> HPLC/MS chromatogram of the muropeptides (positive mode). The first bracket embraces the peaks representing muropeptide monomers, the second the muropeptide dimers. <bold>(C)</bold> Extracted ion chromatograms of the negative mode from the PG precursors isolated from cells grown in R5 (balhimycin production) and in TSB (no balhimycin production). <sc>d</sc>-Lac, Pentapeptide precursors ending on <sc>d</sc>-Ala-<sc>d</sc>-Lac 1194&#x02009;<italic>m/z</italic> at retention time &#x0223c;18&#x02009;min<sc>. d</sc>-Ala, Pentapeptide precursors ending on <sc>d</sc>-Ala-<sc>d</sc>-Ala 1193&#x02009;<italic>m/z</italic> at retention time &#x0223c;12&#x02009;min. HPLC, high-performance liquid chromatography; MS, mass spectrometry; PG, peptidoglycan; WT, wild type.</p></caption><graphic xlink:href="fig-2"/></fig><p>In addition to muropeptides, the PG precursors were analyzed. For this purpose, we cultivated the strains under balhimycin production conditions and conditions under which balhimycin production is disabled. Under production as well as under nonproduction conditions, <italic>A. balhimycina</italic> WT, <italic>A. balhimycina</italic> [<italic>vnlR<sub>Ab</sub></italic>], <italic>A. balhimycina</italic> &#x00394;<italic>vnlR<sub>Ab</sub></italic>, and <italic>A. balhimycina</italic> &#x00394;<italic>vnlR<sub>Ab</sub></italic> [<italic>vnlR<sub>Ab</sub></italic>] produced resistant PG precursors ending with <sc>d</sc>-Ala-<sc>d</sc>-Lac (<xref ref-type="fig" rid="f2">Fig. 2C</xref>). Only <italic>A. balhimycina</italic> WT and <italic>A. balhimycina</italic> &#x00394;<italic>vnlR<sub>Ab</sub></italic> [<italic>vnlR<sub>Ab</sub></italic>] produced traces of precursors ending with <sc>d</sc>-Ala<sc>-d</sc>-Ala under nonproduction conditions (<xref ref-type="fig" rid="f2">Fig. 2C</xref>). These results suggest that VnlR<sub>Ab</sub> does not regulate the synthesis of resistance PG in <italic>A. balhimycina</italic>.</p><p>RT-PCR analyses revealed that a <italic>vanHAX<sub>Ab</sub></italic> transcript was detectable in <italic>A. balhimycina</italic> &#x00394;<italic>vnlR<sub>Ab</sub></italic>, confirming that the expression of <italic>vanHAX<sub>Ab</sub></italic> is independent of <italic>vnlR<sub>Ab</sub></italic> (<xref ref-type="fig" rid="f3">Fig. 3</xref>).</p><fig id="f3" fig-type="figure" orientation="portrait" position="float"><label><bold>FIG. 3.</bold></label><caption><p>RT-PCR analyses of <italic>vanHAX<sub>Ab</sub></italic> and <italic>vanY<sub>Ab</sub></italic> in <italic>A. balhimycina</italic> WT, <italic>A. balhimycina</italic> &#x00394;<italic>vnlR<sub>Ab</sub></italic>, and in <italic>A. balhimycina</italic> WT overexpressing <italic>vnlR<sub>Ab</sub></italic> (WT [<italic>vnlR<sub>Ab</sub></italic>]). RNA was isolated at different time points (15/39/63&#x02009;hr) from the three strains cultivated in balhimycin production medium R5. <italic>sigB</italic>: transcription of the housekeeping gene <italic>sigB</italic>. <italic>vanHAX<sub>Ab</sub></italic> and <italic>vanY<sub>Ab</sub></italic>: transcription of <italic>vanHAX<sub>Ab</sub></italic> and <italic>vanY<sub>Ab</sub></italic>. For PCR, genomic DNA (gDNA) was used as positive control.</p></caption><graphic xlink:href="fig-3"/></fig></sec><sec id="s014"><title>In <italic>A. balhimycina</italic>, sensing of glycopeptides through VnlS<sub>Ab</sub> is not required for expressing the resistance genes</title><p>In enterococci and in <italic>S. coelicolor</italic>, the RR VanR<sub>Sc</sub> becomes phosphorylated by the HK VanS<sub>Sc</sub>. To analyze whether and how VnlR<sub>Ab</sub> interacts with VnlS<sub>Ab</sub>, we constructed an in-frame &#x00394;<italic>vnlS<sub>Ab</sub></italic> mutant of <italic>A. balhimycina</italic> using the inactivation plasmid pSP&#x00394;vnlS<sub>Ab</sub>. This plasmid containing a 1509&#x02009;bp downstream fragment and a 1579&#x02009;bp upstream fragment of <italic>vnlS<sub>Ab</sub></italic> was introduced into <italic>A. balhimycina</italic> through direct transformation. Successive homologous recombination resulted in the deletion of <italic>vnlS<sub>Ab</sub></italic>. <italic>A. balhimycina</italic> &#x00394;<italic>vnlS<sub>Ab</sub></italic> showed neither a defect in balhimycin production nor resistance toward glycopeptides. In addition, no changes in the PG precursor and in the nascent PG composition in comparison with <italic>A. balhimycina</italic> WT were observed (data not shown). These results suggested that sensing the presence of glycopeptides does not correlate with balhimycin production and glycopeptide resistance. Apparently, the expression of the <italic>vanHAX<sub>Ab</sub></italic> genes occurs independently of VnlS<sub>Ab</sub>.</p></sec><sec id="s015"><title>VnlR<sub>Ab</sub> is able to activate <italic>vanHAX<sub>Sc</sub></italic> transcription in <italic>S. coelicolor</italic></title><p><italic>In silico</italic> analyses revealed similar characteristics of VnlRS<sub>Ab</sub> compared with VanRS<sub>Sc</sub>. However, as shown above, the VnlRS<sub>Ab</sub> system in <italic>A. balhimycina</italic>, in contrast to VanRS<sub>Sc</sub> in <italic>S. coelicolor</italic>, does not regulate the <italic>vanHAX<sub>Ab</sub></italic>. To clarify the contradictory findings, the genes encoding the TCS VnlRS<sub>Ab</sub> as well as VnlR<sub>Ab</sub> and VnlS<sub>Ab</sub> individually were transferred into the <italic>S. coelicolor</italic> mutant strain, in which the <italic>vanRS<sub>Sc</sub></italic> genes were deleted,<sup><xref rid="B6" ref-type="bibr">6</xref></sup> to elucidate the ability of VnlR<sub>Ab</sub> to activate the <italic>vanHAX<sub>Sc</sub></italic> genes in the <italic>S. coelicolor</italic> mutant. <italic>vnlRS<sub>Ab</sub></italic>, <italic>vnlR<sub>Ab</sub></italic>, <italic>and vnlS<sub>Ab</sub></italic> were introduced into <italic>S. coelicolor</italic> &#x00394;<italic>vanRS<sub>Sc</sub></italic> under the control of the constitutive promoter <italic>ermE</italic>p* using the integrative plasmid pRM4vnlR<sub>Ab</sub>. The growth of the recombinant strains was tested on glycopeptide-containing plates.</p><p>Introduction of <italic>vnlRS<sub>Ab</sub></italic> and of <italic>vnlR<sub>Ab</sub></italic> alone into <italic>S. coelicolor</italic> M600 &#x00394;<italic>vanRS<sub>Sc</sub></italic> resulted in balhimycin-resistant strains (<xref ref-type="fig" rid="f4">Fig. 4</xref>). In contrast, expression of <italic>vnlS<sub>Ab</sub></italic> alone did not change the glycopeptide-sensitive phenotype of the <italic>S. coelicolor</italic> &#x00394;<italic>vanRS<sub>Sc</sub></italic> mutant. These results indicated that VnlR<sub>Ab</sub> from <italic>A. balhimycina</italic> is able to activate the transcription of <italic>vanHAX</italic><sub>Sc</sub> in <italic>S. coelicolor</italic> M600 also in the absence of VnlS<sub>Ab</sub>. Since in <italic>S. coelicolor</italic> M600 VanR<sub>Sc</sub>&#x0223c;P can be generated in a VanS<sub>Sc</sub>-independent manner using acetylphosphate,<sup><xref rid="B6" ref-type="bibr">6</xref></sup> we suggest a similar activation of VnlR<sub>Ab</sub> in the absence of VnlS<sub>Ab</sub> or VanS<sub>Sc</sub>.</p><fig id="f4" fig-type="figure" orientation="portrait" position="float"><label><bold>FIG. 4.</bold></label><caption><p>Growth and resistance of the <italic>S. coelicolor</italic> M600 <italic>&#x00394;vanRS<sub>Sc</sub></italic> complemented with different combinations of <italic>vnlRS<sub>Ab</sub></italic>. <bold>(A)</bold> Growth on YM agar containing no antibiotic. <bold>(B)</bold> Growth on YM agar containing apramycin (100&#x02009;mg/ml) (Apra 100) to prove plasmid integration. <bold>(C)</bold> Growth on YM agar containing balhimycin (10&#x02009;mg/ml) (Bal 10). <bold>(D)</bold> Growth on YM agar containing teicoplanin (10&#x02009;mg/ml) (Teico 10). <bold>(E)</bold> Growth on YM agar containing no antibiotic. M600, <italic>S. coelicolor</italic> M600.</p></caption><graphic xlink:href="fig-4"/></fig><p>The activation of the <italic>vanHAX<sub>Sc</sub></italic> genes in the complemented <italic>S. coelicolor</italic> M600 &#x00394;<italic>vanRS<sub>Sc</sub></italic> mutant with <italic>vnlRS<sub>Ab</sub></italic> and <italic>vnlR<sub>Ab</sub></italic> was further analyzed by RT-PCR. For this purpose, RNA was isolated from 25-hr-old liquid cultures grown without addition of any glycopeptide. A <italic>vanHAX<sub>Sc</sub></italic> transcript was detected when <italic>S. coelicolor</italic> M600 &#x00394;<italic>vanRS<sub>Sc</sub></italic> was complemented with <italic>vnlRS<sub>Ab</sub></italic> or with <italic>vnlR<sub>Ab</sub></italic> alone. However, in <italic>S. coelicolor</italic> M600 and in the <italic>S. coelicolor</italic> M600 &#x00394;<italic>vanRS<sub>Sc</sub></italic> mutant, transcription of the <italic>vanHAX<sub>Sc</sub></italic> failed (<xref ref-type="fig" rid="f5">Fig. 5</xref>), confirming the functionality of VnlR<sub>Ab</sub> as transcriptional activator in <italic>S. coelicolor</italic>.</p><fig id="f5" fig-type="figure" orientation="portrait" position="float"><label><bold>FIG. 5.</bold></label><caption><p>RT-PCR analyses of <italic>S. coelicolor</italic> M600 and different <italic>S. coelicolor</italic> M600 mutants. RNA was isolated after 25&#x02009;hr of cultivation in the absence of any glycopeptide. <italic>hrdB</italic>: transcription of the housekeeping gene <italic>hrdB<sub>Sc</sub></italic>. <italic>vanS<sub>Sc</sub></italic>, <italic>vanR<sub>Sc</sub></italic>, and <italic>vanHAX<sub>Sc</sub></italic>: transcription of <italic>vanS<sub>Sc</sub></italic>, <italic>vanR<sub>Sc</sub></italic>, and <italic>vanHAX<sub>Sc</sub></italic>. For PCR, genomic DNA (gDNA) was used as positive control.</p></caption><graphic xlink:href="fig-5"/></fig><p>To investigate whether transcription of the <italic>vanHAX<sub>Sc</sub></italic> genes indeed resulted in the formation of glycopeptide-resistant PG precursors, which caused the resistant phenotype, we used HPLC/MS to analyze the PG precursor composition of <italic>S. coelicolor</italic> M600 &#x00394;<italic>vanRS<sub>Sc</sub></italic> and of <italic>S. coelicolor</italic> M600 &#x00394;<italic>vanRS<sub>Sc</sub></italic> complemented either with <italic>vnlRS<sub>Ab</sub></italic> or <italic>vnlR<sub>Ab</sub></italic>. Complementing <italic>S. coelicolor</italic> M600 &#x00394;<italic>vanRS<sub>Sc</sub></italic> with <italic>vnlRS<sub>Ab</sub></italic> or with <italic>vnlR<sub>Ab</sub></italic> restored the synthesis of resistant PG precursors. In the presence of balhimycin exclusively, PG precursors ending with <sc>d</sc>-Ala-<sc>d</sc>-Lac were synthesized (<xref ref-type="fig" rid="f6">Fig. 6C, D</xref>). The PG precursor composition of the glycopeptide-sensitive <italic>S. coelicolor</italic> M600 &#x00394;<italic>vanRS<sub>Sc</sub></italic> mutant was analyzed after growing the strain in the absence of balhimycin. In this mutant, only sensitive cell wall precursors ending on <sc>d</sc>-Ala-<sc>d</sc>-Ala (1193&#x02009;m/z) eluting at a retention time of 10&#x02013;11&#x02009;min were detected (<xref ref-type="fig" rid="f6">Fig. 6A</xref>).</p><fig id="f6" fig-type="figure" orientation="portrait" position="float"><label><bold>FIG. 6.</bold></label><caption><p>Extracted ion chromatograms (negative mode) of the PG precursors isolated from cells grown in R5 medium without antibiotic or with 25&#x02009;mg/ml balhimycin (bal25). M600 &#x00394;<italic>vanRS<sub>Sc</sub></italic>: <italic>S. coelicolor</italic> M600 &#x00394;<italic>vanRS<sub>Sc</sub></italic>; <sc>d</sc>-Lac, pentapeptide precursors ending on <sc>d</sc>-Ala-<sc>d</sc>-Lac 1194&#x02009;m/z at retention time &#x0223c;18&#x02009;min; <sc>d</sc>-Ala, pentapeptide precursors ending on <sc>d</sc>-Ala-<sc>d</sc>-Ala 1193&#x02009;<italic>m/z</italic> at retention time &#x0223c;14&#x02009;min.</p></caption><graphic xlink:href="fig-6"/></fig></sec><sec id="s016"><title>The phosphorylation site D51 is essential for the function of VnlR<sub>Ab</sub></title><p>To define the phosphorylation site of VnlR<sub>Ab</sub>, D51, which was identified as a likely phosphorylation site by sequence composition (<xref ref-type="fig" rid="f1">Fig. 1</xref>), was replaced by an alanine by exchanging nucleotide A to C at position 161 of <italic>vnlR<sub>Ab</sub></italic> using the recombinant PCR method. The exchange was verified by sequence analysis. The mutated gene was cloned into the integrative vector pRM4 under the control of the <italic>ermE</italic>p* promoter and introduced into <italic>S. coelicolor</italic> M600 &#x00394;<italic>vanRS<sub>Sc</sub>.</italic> The resulting recombinant strain was not able to grow in the presence of the tested glycopeptides (<xref ref-type="fig" rid="f4">Fig. 4</xref>). Therefore, we propose D51 as the VnlR<sub>Ab</sub> phosphorylation site.</p></sec><sec id="s017"><title>VnlR<sub>Ab</sub> expands the glycopeptide resistance in <italic>S. coelicolor</italic></title><p>The glycopeptide resistance mechanism in <italic>S. coelicolor</italic> belongs to the VanB type of resistance, meaning that glycopeptide resistance can only be induced by vancomycin or vancomycin-type glycopeptides, whereas teicoplanin (a type IV glycopeptide) fails to activate resistance,<sup><xref rid="B42" ref-type="bibr">42</xref></sup> resulting in a teicoplanin-sensitive phenotype of <italic>S. coelicolor</italic>. In contrast, <italic>A. balhimycina</italic> is resistant against vancomycin- as well as teicoplanin-type glycopeptides. To analyze whether the RR is responsible for determination of the glycopeptide resistance type, the recombinant strains <italic>S. coelicolor</italic> &#x00394;<italic>vanRS<sub>Sc</sub></italic> [<italic>vnlRS<sub>Ab</sub></italic>], <italic>S. coelicolor</italic> &#x00394;<italic>vanRS<sub>Sc</sub></italic> [<italic>vnlR<sub>Ab</sub></italic>], <italic>S. coelicolor</italic> &#x00394;<italic>vanRS<sub>Sc</sub></italic> [<italic>vnlS<sub>Ab</sub></italic>], and <italic>S. coelicolor</italic> &#x00394;<italic>vanRS<sub>Sc</sub></italic> [<italic>vnlRS<sub>Ab</sub></italic> D51A] were grown on teicoplanin-containing plates. Surprisingly, the recombinant strains (<italic>S. coelicolor</italic> &#x00394;<italic>vanRS<sub>Sc</sub></italic> [<italic>vnlRS<sub>Ab</sub></italic>], <italic>S. coelicolor</italic> &#x00394;<italic>vanRS<sub>Sc</sub></italic> [<italic>vnlR<sub>Ab</sub></italic>]) were able to grow also on teicoplanin-containing plates, whereas growth of <italic>S. coelicolor</italic> M600 WT was inhibited (<xref ref-type="fig" rid="f4">Fig. 4</xref>). These results indicated that VnlR<sub>Ab</sub> is able to induce teicoplanin resistance in <italic>S. coelicolor</italic> M600 by probably activating further genes required for teicoplanin resistance.</p></sec><sec id="s018"><title>VnlR<sub>Ab</sub> influences antibiotic production in <italic>S. coelicolor</italic></title><p>To analyze if the heterologous expression of VnlR<sub>Ab</sub>, in addition to the activation of the <italic>vanHAX<sub>Sc</sub></italic> genes, causes further (morphological) changes in <italic>S. coelicolor</italic> M600, the growth and production of actinorhodin were investigated without the addition of any antibiotic. Similar titers of spores (1.5&#x02009;&#x000d7;&#x02009;10<sup>7</sup>) of <italic>S. coelicolor</italic> M600, <italic>S. coelicolor</italic> &#x00394;<italic>vanRS<sub>Sc</sub></italic>, <italic>S. coelicolor</italic> &#x00394;<italic>vanRS<sub>Sc</sub></italic> [<italic>vnlRS<sub>Ab</sub></italic>], <italic>S. coelicolor</italic> &#x00394;<italic>vanRS<sub>Sc</sub></italic> [<italic>vnlR<sub>Ab</sub></italic>], <italic>S. coelicolor</italic> &#x00394;<italic>vanRS<sub>Sc</sub></italic> [<italic>vnlS<sub>Ab</sub></italic>], and <italic>S. coelicolor</italic> &#x00394;<italic>vanRS<sub>Sc</sub></italic> [<italic>vnlRS<sub>Ab</sub></italic> D51A] were plated on YM medium. Surprisingly, the heterologous expression of <italic>vnlRS<sub>Ab</sub></italic> or <italic>vnlR<sub>Ab</sub></italic> alone in <italic>S. coelicolor</italic> M600 &#x00394;<italic>vanRS<sub>Sc</sub></italic> caused retardation in growth and increased actinorhodin production (<xref ref-type="fig" rid="f4">Fig. 4E</xref>).</p><p>These results suggested that VnlR<sub>Ab</sub> is not only able to activate the <italic>vanHAX<sub>Sc</sub></italic> genes in <italic>S. coelicolor</italic> M600 and to change its glycopeptide resistance type but it also has effects on other genes in <italic>S. coelicolor</italic> M600.</p></sec><sec id="s019"><title>VnlR<sub>Ab</sub> is responsible for the activation of <italic>vanY<sub>Ab</sub></italic></title><p>Heterologous expression of VnlR<sub>Ab</sub> in <italic>S. coelicolor</italic> confirmed that it can take over the VanR<sub>Sc</sub> function to induce the expression of the <italic>vanHAX<sub>Ab</sub></italic> genes and, in addition, can apparently induce the expression of further genes. In contrast, it is not involved in regulation of the <italic>vanHAX<sub>Ab</sub></italic> genes in <italic>A. balhimycina</italic>. Since regulatory genes are often colocalized with its target genes, we speculated that VnlRS<sub>Ab</sub> might control <italic>vanY<sub>Ab</sub></italic>, which is located directly adjacent to <italic>vnlR<sub>Ab</sub></italic> and which encodes a carboxypeptidase. Previous studies showed that VanY<sub>Ab</sub> cleaves the <sc>d</sc>-Ala<sc>-d</sc>-Ala dipeptide from the PG precursors, but it is not able to cleave the <sc>d</sc>-Ala<sc>-d</sc>-Lac depsipeptide.<sup><xref rid="B27" ref-type="bibr">27</xref></sup> To investigate, whether VnlR<sub>Ab</sub> regulates the expression of <italic>vanY<sub>Ab</sub></italic>, transcriptional analyses were performed. RT-PCR analyses revealed that <italic>vanY<sub>Ab</sub></italic> was only transcribed when <italic>vnlR<sub>Ab</sub></italic> was expressed under the control of the strong promoter <italic>ermE*p</italic> (<xref ref-type="fig" rid="f2">Fig. 2</xref> (<italic>A. balhimycina</italic> [<italic>vnlR<sub>Ab</sub></italic>]). In <italic>A. balhimycina</italic> WT, transcription was detectable on a low level only after 63&#x02009;hr of cultivation and in the <italic>A. balhimycina</italic> &#x00394;<italic>vnlR<sub>Ab</sub></italic> mutant, <italic>vanY<sub>Ab</sub></italic> transcription was not induced at all (<xref ref-type="fig" rid="f2">Fig. 2</xref>). This result was confirmed by RNA-seq analyses where we compared the transcription level of <italic>vanY<sub>Ab</sub></italic> in the <italic>A. balhimycina</italic> WT and <italic>A. balhimycina</italic> &#x00394;<italic>vnlR<sub>Ab</sub></italic> (data not shown). The transcription of <italic>vanY<sub>Ab</sub></italic> was 25-fold decreased in <italic>A. balhimycina</italic> &#x00394;<italic>vnlR<sub>Ab</sub></italic> compared with <italic>A. balhimycina</italic> WT. We therefore concluded that the RR VnlR<sub>Ab</sub> in <italic>A. balhimycina</italic> is involved in controlling the expression of resistance mediated by VanY<sub>Ab</sub>.</p></sec></sec><sec sec-type="discussion" id="s020"><title>Discussion</title><p>Glycopeptide resistance in pathogens and in <italic>S. coelicolor</italic> is mediated by the action of VanHAX. The expression of the <italic>vanHAX</italic> genes is regulated by the TCS VanRS, the genes of which are colocalized with <italic>vanHAX</italic>. In the presence of glycopeptides, VanS becomes autophosphorylated and phosphorylates VanR, which subsequently activates transcription of <italic>vanHAX</italic>. VanH, VanA, and VanH reprogram the biosynthesis of the PG precursors, resulting in lipid II with an N-terminal <sc>d</sc>-Ala-<sc>d</sc>-Lac depsipeptide instead of the normally occurring <sc>d</sc>-Ala-<sc>d</sc>-Ala termini, the target of the glycopeptides. <italic>A. balhimycina</italic> produces the vancomycin-like glycopeptide balhimycin and has to protect itself from the action of the glycopeptide.<sup><xref rid="B45" ref-type="bibr">45</xref></sup> The genome of <italic>A. balhimycina</italic> includes <italic>vanHAX<sub>Ab</sub></italic> genes and <italic>vanRS</italic>-like genes (<italic>vnlRS<sub>Ab</sub></italic>). However, in contrast to other glycopeptide-resistant bacteria, the <italic>vanHAX<sub>Ab</sub></italic> genes in <italic>A. balhimycina</italic> are located 2 Mb apart from the <italic>vnlRS<sub>Ab</sub></italic> genes, which are part of the balhimycin biosynthetic gene cluster.<sup><xref rid="B40" ref-type="bibr">40</xref></sup></p><p>RT-PCR experiments revealed that VnlR<sub>Ab</sub> is not involved in the activation of the <italic>vanHAX<sub>A</sub></italic><sub>b</sub> genes in <italic>A. balhimycina</italic>. Subsequent PG analyses confirmed that a <italic>vnlR<sub>Ab</sub></italic> deletion mutant cannot synthesize resistant muropeptides. Since <italic>vnlR<sub>Ab</sub></italic> is colocalized with the balhimycin biosynthetic genes, an alternative role of VnlR<sub>Ab</sub> as regulator of balhimycin synthesis was assumed, but the deletion of the <italic>vnlR<sub>Ab</sub></italic> did not affect balhimycin production. Hence, VnlR<sub>Ab</sub> is not the central regulator activating the <italic>vanHAX<sub>A</sub></italic><sub>b</sub> resistance genes or the balhimycin biosynthetic genes.</p><p>To further investigate the potential target gene(s) of VnlR<sub>Ab</sub>, we analyzed the transcription of <italic>vanY<sub>Ab</sub></italic>, which encodes a carboxypeptidase and which is located adjacent to the <italic>vnlRS<sub>Ab</sub></italic> genes in the balhimycin biosynthetic gene cluster.<sup><xref rid="B25" ref-type="bibr">25</xref></sup> RT-PCR and RNA-seq analyses revealed that <italic>vanY<sub>Ab</sub></italic> expression was 25-fold decreased in <italic>A. balhimycina</italic> &#x00394;vnlR<sub>Ab</sub> compared with <italic>A. balhimycina</italic> WT.</p><p>VanY<sub>Ab</sub> is a <sc>d,d</sc>-carboxypeptidase, which cleaves the endstanding <sc>d</sc>-Ala from lipid II, resulting in the formation of tetrapeptides.<sup><xref rid="B27" ref-type="bibr">27</xref></sup> In contrast to other described carboxypeptidases,<sup><xref rid="B46" ref-type="bibr">46</xref></sup> VanY<sub>Ab</sub> has no <sc>d,d</sc>-carboxyesterase activity. The tetrapeptides are the substrates for the <sc>l</sc>,<sc>d</sc>-transpeptidase (Ldt), which subsequently cross-links the tetrapeptide acyl donors at the third AA. This results in PG with 3&#x02013;3 cross-linked tetra- and tripeptides, which are devoid of the <sc>d</sc>-Ala-<sc>d</sc>-Ala-ending peptides, and which can therefore not serve as target of glycopeptides anymore.<sup><xref rid="B47" ref-type="bibr">47</xref></sup> Investigations of the PG of <italic>A. balhimycina</italic> revealed the presence of 3&#x02013;3 cross-linked tetra- and tripeptides.<sup><xref rid="B40" ref-type="bibr">40</xref>,<xref rid="B45" ref-type="bibr">45</xref></sup> Furthermore, we could identify at least three <italic>ldt</italic> genes in the genome of <italic>A. balhimycina</italic>.<sup><xref rid="B45" ref-type="bibr">45</xref></sup> We therefore speculate that by activating the expression of <italic>vanY<sub>Ab</sub></italic>, VnlR<sub>Ab</sub> is involved in regulating an alternative, VanHAX<sub>Ab</sub>-independent glycopeptide resistance mechanism in <italic>A. balhimycina</italic>. This fact is further confirmed by RT-PCR analysis, where it was shown that VanY<sub>Ab</sub> is expressed in <italic>A. balhimycina</italic> &#x00394;<italic>vanHAX<sub>Ab</sub></italic>.<sup><xref rid="B40" ref-type="bibr">40</xref></sup></p><p>This observation is in accordance with the findings in <italic>Nonomuraea</italic> ATCC 39727, the producer of the dalbavancin precursor A40926. <italic>Nonomuraea</italic> ATCC 39727 does not encode VanHAX homologs, but possesses a VanY homolog (VanY<sub>n</sub><italic>)</italic> for the synthesis of a resistant PG precursor.<sup><xref rid="B48" ref-type="bibr">48</xref></sup> As described for <italic>A. balhimycina</italic>, VanY<sub>n</sub> cleaves the C-terminal <sc>d</sc>-Ala from the pentapeptide as well as from the <sc>d</sc>-Ala-<sc>d</sc>-Ala dipeptide. The tetrapeptides are subsequently cross-linked by Ldt, resulting in glycopeptide-resistant cell wall.<sup><xref rid="B47" ref-type="bibr">47</xref></sup> The surprising features of VnlR<sub>Ab</sub> are that although it does not regulate the transcription of the <italic>vanHAX<sub>Ab</sub></italic> genes in <italic>A. balhimycina</italic>, it is able to activate <italic>vanHAX<sub>Sc</sub></italic> transcription in <italic>S. coelicolor</italic>, and that it activates teicoplanin resistance in <italic>S. coelicolor</italic>.</p><p>Activation of the <italic>vanHAX<sub>Sc</sub></italic> transcription can be explained by the binding of VnlR<sub>Ab</sub> at the promoter region of <italic>vanHAX<sub>Sc</sub>.</italic> Sequence comparison of the promoter regions of <italic>vanHAX<sub>Sc</sub></italic> and <italic>vanHAX<sub>Ab</sub></italic> not only revealed conserved motives but also some differences (data not shown). Although many attempts have been made to analyze putative promoter sequences in gel mobility assays, no shifts could be observed. This is probably due to the fact that after purification, the protein lost its functionality (data not shown). Therefore, determination of the exact binding motive of VnlR<sub>Ab</sub> still requires alternative approaches.</p><p>VnlR<sub>Ab</sub> was not only able to restore vancomycin resistance in an <italic>S. coelicolor</italic> &#x00394;<italic>vanRS<sub>Ab</sub></italic> mutant after heterologous expression but it even conferred teicoplanin resistance to this mutant, although <italic>S. coelicolor</italic> WT is sensitive toward teicoplanin. Recent comparative study of the VanR-VanS systems from two <italic>Streptomyces</italic> strains, <italic>S. coelicolor</italic> and <italic>Streptomyces toyocaensis</italic> (the producer of the sugarless glycopeptide A47934), indicated that the glycopeptide antibiotic inducer specificity is determined solely by the differences between the AA sequences of the VanR-VanS TCS present in each strain rather than by any inherent differences in general cell properties, including cell wall structure and biosynthesis.<sup><xref rid="B42" ref-type="bibr">42</xref></sup> On the one hand, the results obtained in this work support this finding; since <italic>vnlR<sub>Ab</sub></italic> is under the control of the <italic>ermEp</italic>* promoter, VnlR<sub>Ab</sub> is constitutively expressed and activates the transcription of the <italic>vanHAXJK<sub>Sc</sub></italic> genes in <italic>S. coelicolor</italic> independent from the presence of any glycopeptide. The activation of <italic>vanHAXJK<sub>Sc</sub></italic> resulted in the synthesis of PG with pentapeptides ending on <sc>d</sc>-Ala-<sc>d</sc>-Lac depsipeptide, which are resistant against vancomycin and teicoplanin. On the other hand, the second explanation contradicts the work of Novotna <italic>et al.</italic><sup><xref rid="B42" ref-type="bibr">42</xref></sup>; it is likely that VnlR<sub>Ab</sub> activates the transcription of additional unknown genes, which mediate teicoplanin resistance.</p><p>The diverse functionality of VnlR<sub>Ab</sub> in the glycopeptide producer <italic>A. balhimycina</italic> and in the nonproducer <italic>S. coelicolor</italic> provides the starting point of evolutionary analyses of glycopeptide resistance. In pathogenic bacteria and in <italic>S. coelicolor</italic> of glycopeptides, resistance is strictly regulated and is induced by the presence of glycopeptides. In contrast, glycopeptide producers overcome this regulation not only by the constitutive expression of the <italic>vanHAX</italic> genes but also by the development of a <italic>vanHAX</italic>-independent resistance mechanism. However, the ability of VnlR<sub>Ab</sub> to activate transcription of <italic>vanHAX</italic> in <italic>S. coelicolor</italic> is an indication of a common origin of the three glycopeptide resistance mechanisms, the inducible one, the constitutively expressed, and the <italic>vanHAX</italic>-independent mechanism. Whether and how the complex resistance mechanism has evolved in the glycopeptide producers and whether and how it was transferred into resistance pathogens have to be subjects of future investigation.</p></sec></body><back><sec id="s021" sec-type="ack"><title>Acknowledgments</title><p>The Deutsche Forschungsgemeinschaft (DFG) supported this work by the SFB 766 program TP-A03. The authors thank Matthew I. Hutchings, Hee-Jeon Hong, and Mark J. Buttner for providing the <italic>S. coelicolor</italic> J3201 mutant and Tobias Busche and Joern Kalinowski for the RNA-seq analyses. The authors further thank Vera Rosenberger and Tobias Martin for competent assistance during the experiments, Sigrid Stockert for technical support, and G&#x000fc;nther Muth for sharing his excellent expertise in the research and writing process.</p></sec><sec id="s022" sec-type="COI-statement"><title>Disclosure Statement</title><p>The authors disclose that there are no commercial associations that might create a conflict of interest in connection with submitted manuscripts.</p></sec><ref-list content-type="parsed"><title>References</title><ref id="B1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laub</surname><given-names>M.T.</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Goulian</surname><given-names>M.</given-names></name></person-group>
<year>2007</year>
<article-title>Specificity in two-component signal transduction pathways</article-title>. <source>Annu. Rev. Genet.</source>
<volume>41</volume>:<fpage>121</fpage>&#x02013;<lpage>145</lpage><pub-id pub-id-type="pmid">18076326</pub-id></mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perry</surname><given-names>J.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Koteva</surname><given-names>K.</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Wright</surname><given-names>G.</given-names></name></person-group>
<year>2011</year>
<article-title>Receptor domains of two-component signal transduction systems</article-title>. <source>Mol. Biosyst.</source>
<volume>7</volume>:<fpage>1388</fpage>&#x02013;<lpage>1398</lpage><pub-id pub-id-type="pmid">21347487</pub-id></mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galperin</surname><given-names>M.Y.</given-names></name></person-group>
<year>2010</year>
<article-title>Diversity of structure and function of response regulator output domains</article-title>. <source>Curr. Opin. Microbiol.</source>
<volume>13</volume>:<fpage>150</fpage>&#x02013;<lpage>159</lpage><pub-id pub-id-type="pmid">20226724</pub-id></mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arthur</surname><given-names>M.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Molinas</surname><given-names>C.</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Courvalin</surname><given-names>P.</given-names></name></person-group>
<year>1992</year>
<article-title>The VanS-VanR two-component regulatory system controls synthesis of depsipeptide peptidoglycan precursors in <italic>Enterococcus faecium</italic> BM4147</article-title>. <source>J. Bacteriol.</source>
<volume>174</volume>:<fpage>2582</fpage>&#x02013;<lpage>2591</lpage><pub-id pub-id-type="pmid">1556077</pub-id></mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gardete</surname><given-names>S.</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Tomasz</surname><given-names>A.</given-names></name></person-group>
<year>2014</year>
<article-title>Mechanisms of vancomycin resistance in <italic>Staphylococcus aureus</italic></article-title>. <source>J. Clin. Invest.</source>
<volume>124</volume>:<fpage>2836</fpage>&#x02013;<lpage>2840</lpage><pub-id pub-id-type="pmid">24983424</pub-id></mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hutchings</surname><given-names>M.I.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hong</surname><given-names>H.J.</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Buttner</surname><given-names>M.J.</given-names></name></person-group>
<year>2006</year>
<article-title>The vancomycin resistance VanRS two-component signal transduction system of <italic>Streptomyces coelicolor</italic></article-title>. <source>Mol. Microbiol.</source>
<volume>59</volume>:<fpage>923</fpage>&#x02013;<lpage>935</lpage><pub-id pub-id-type="pmid">16420361</pub-id></mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheung</surname><given-names>J.</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Hendrickson</surname><given-names>W.A.</given-names></name></person-group>
<year>2010</year>
<article-title>Sensor domains of two-component regulatory systems</article-title>. <source>Curr. Opin. Microbiol.</source>
<volume>13</volume>:<fpage>116</fpage>&#x02013;<lpage>123</lpage><pub-id pub-id-type="pmid">20223701</pub-id></mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gold</surname><given-names>H.S.</given-names></name></person-group>
<year>2001</year>
<article-title>Vancomycin-resistant enterococci: mechanisms and clinical observations</article-title>. <source>Clin. Infect. Dis.</source>
<volume>33</volume>:<fpage>210</fpage>&#x02013;<lpage>219</lpage><pub-id pub-id-type="pmid">11418881</pub-id></mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pootoolal</surname><given-names>J.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Neu</surname><given-names>J.</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Wright</surname><given-names>G.D.</given-names></name></person-group>
<year>2002</year>
<article-title>Glycopeptide antibiotic resistance</article-title>. <source>Annu. Rev. Pharmacol. Toxicol.</source>
<volume>42</volume>:<fpage>381</fpage>&#x02013;<lpage>408</lpage><pub-id pub-id-type="pmid">11807177</pub-id></mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>X.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lin</surname><given-names>D.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Yan</surname><given-names>G.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ye</surname><given-names>X.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wu</surname><given-names>S.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Guo</surname><given-names>Y.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zhu</surname><given-names>D.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hu</surname><given-names>F.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wang</surname><given-names>F.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Jacoby</surname><given-names>G.A.</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Wang</surname><given-names>M.</given-names></name></person-group>
<year>2010</year>
<article-title><italic>vanM</italic>, a new glycopeptide resistance gene cluster found in <italic>Enterococcus faecium</italic></article-title>. <source>Antimicrob. Agents Chemother.</source>
<volume>54</volume>:<fpage>4643</fpage>&#x02013;<lpage>4647</lpage><pub-id pub-id-type="pmid">20733041</pub-id></mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bugg</surname><given-names>T.D.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wright</surname><given-names>G.D.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dutka-Malen</surname><given-names>S.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Arthur</surname><given-names>M.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Courvalin</surname><given-names>P.</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Walsh</surname><given-names>C.T.</given-names></name></person-group>
<year>1991</year>
<article-title>Molecular basis for vancomycin resistance in <italic>Enterococcus faecium</italic> BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA</article-title>. <source>Biochemistry.</source>
<volume>30</volume>:<fpage>10408</fpage>&#x02013;<lpage>10415</lpage><pub-id pub-id-type="pmid">1931965</pub-id></mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Billot-Klein</surname><given-names>D.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Blanot</surname><given-names>D.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gutmann</surname><given-names>L.</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>van Heijenoort</surname><given-names>J.</given-names></name></person-group>
<year>1994</year>
<article-title>Association constants for the binding of vancomycin and teicoplanin to N-acetyl-D-alanyl-D-alanine and N-acetyl-D-alanyl-D-serine</article-title>. <source>Biochem. J.</source>
<volume>304</volume> (<issue>Pt 3</issue>):<fpage>1021</fpage>&#x02013;<lpage>1022</lpage><pub-id pub-id-type="pmid">7818465</pub-id></mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reynolds</surname><given-names>P.E.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Snaith</surname><given-names>H.A.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Maguire</surname><given-names>A.J.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dutka-Malen</surname><given-names>S.</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Courvalin</surname><given-names>P.</given-names></name></person-group>
<year>1994</year>
<article-title>Analysis of peptidoglycan precursors in vancomycin-resistant <italic>Enterococcus gallinarum</italic> BM4174</article-title>. <source>Biochem. J.</source>
<volume>301</volume> (<issue>Pt 1</issue>):<fpage>5</fpage>&#x02013;<lpage>8</lpage><pub-id pub-id-type="pmid">8037690</pub-id></mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perichon</surname><given-names>B.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Reynolds</surname><given-names>P.</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Courvalin</surname><given-names>P.</given-names></name></person-group>
<year>1997</year>
<article-title>VanD-type glycopeptide-resistant <italic>Enterococcus faecium</italic> BM4339</article-title>. <source>Antimicrob. Agents Chemother.</source>
<volume>41</volume>:<fpage>2016</fpage>&#x02013;<lpage>2018</lpage><pub-id pub-id-type="pmid">9303405</pub-id></mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lebreton</surname><given-names>F.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Depardieu</surname><given-names>F.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bourdon</surname><given-names>N.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Fines-Guyon</surname><given-names>M.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Berger</surname><given-names>P.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Camiade</surname><given-names>S.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Leclercq</surname><given-names>R.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Courvalin</surname><given-names>P.</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Cattoir</surname><given-names>V.</given-names></name></person-group>
<year>2011</year>
<article-title>D-Ala-D-Ser VanN-type transferable vancomycin resistance in <italic>Enterococcus faecium</italic></article-title>. <source>Antimicrob. Agents Chemother.</source>
<volume>55</volume>:<fpage>4606</fpage>&#x02013;<lpage>4612</lpage><pub-id pub-id-type="pmid">21807981</pub-id></mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nomura</surname><given-names>T.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Tanimoto</surname><given-names>K.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Shibayama</surname><given-names>K.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Arakawa</surname><given-names>Y.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Fujimoto</surname><given-names>S.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ike</surname><given-names>Y.</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Tomita</surname><given-names>H.</given-names></name></person-group>
<year>2012</year>
<article-title>Identification of VanN-type vancomycin resistance in an <italic>Enterococcus faecium</italic> isolate from chicken meat in Japan</article-title>. <source>Antimicrob. Agents Chemother.</source>
<volume>56</volume>:<fpage>6389</fpage>&#x02013;<lpage>6392</lpage><pub-id pub-id-type="pmid">23006756</pub-id></mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foucault</surname><given-names>M.L.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Courvalin</surname><given-names>P.</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Grillot-Courvalin</surname><given-names>C.</given-names></name></person-group>
<year>2009</year>
<article-title>Fitness cost of VanA-type vancomycin resistance in methicillin-resistant <italic>Staphylococcus aureus</italic></article-title>. <source>Antimicrob. Agents Chemother.</source>
<volume>53</volume>:<fpage>2354</fpage>&#x02013;<lpage>2359</lpage><pub-id pub-id-type="pmid">19332680</pub-id></mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foucault</surname><given-names>M.L.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Depardieu</surname><given-names>F.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Courvalin</surname><given-names>P.</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Grillot-Courvalin</surname><given-names>C.</given-names></name></person-group>
<year>2010</year>
<article-title>Inducible expression eliminates the fitness cost of vancomycin resistance in enterococci</article-title>. <source>Proc. Natl. Acad. Sci. U S A</source>
<volume>107</volume>:<fpage>16964</fpage>&#x02013;<lpage>16969</lpage><pub-id pub-id-type="pmid">20833818</pub-id></mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>H.J.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hutchings</surname><given-names>M.I.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Neu</surname><given-names>J.M.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wright</surname><given-names>G.D.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Paget</surname><given-names>M.S.</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Buttner</surname><given-names>M.J.</given-names></name></person-group>
<year>2004</year>
<article-title>Characterization of an inducible vancomycin resistance system in <italic>Streptomyces coelicolor</italic> reveals a novel gene (<italic>vanK</italic>) required for drug resistance</article-title>. <source>Mol. Microbiol.</source>
<volume>52</volume>:<fpage>1107</fpage>&#x02013;<lpage>1121</lpage><pub-id pub-id-type="pmid">15130128</pub-id></mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novotna</surname><given-names>G.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hill</surname><given-names>C.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Vincent</surname><given-names>K.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Liu</surname><given-names>C.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hong</surname><given-names>H.J.</given-names></name></person-group>
<year>2012</year>
<article-title>A novel membrane protein, VanJ, conferring resistance to teicoplanin</article-title>. <source>Antimicrob. Agents Chemother.</source>
<volume>56</volume>:<fpage>1784</fpage>&#x02013;<lpage>1796</lpage><pub-id pub-id-type="pmid">22232274</pub-id></mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koteva</surname><given-names>K.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hong</surname><given-names>H.J.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wang</surname><given-names>X.D.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Nazi</surname><given-names>I.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hughes</surname><given-names>D.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Naldrett</surname><given-names>M.J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Buttner</surname><given-names>M.J.</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Wright</surname><given-names>G.D.</given-names></name></person-group>
<year>2010</year>
<article-title>A vancomycin photoprobe identifies the histidine kinase VanSsc as a vancomycin receptor</article-title>. <source>Nat. Chem. Biol.</source>
<volume>6</volume>:<fpage>327</fpage>&#x02013;<lpage>329</lpage><pub-id pub-id-type="pmid">20383152</pub-id></mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwun</surname><given-names>M.J.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Novotna</surname><given-names>G.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hesketh</surname><given-names>A.R.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hill</surname><given-names>L.</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Hong</surname><given-names>H.-J.</given-names></name></person-group>
<year>2013</year>
<article-title>In vivo studies suggest that induction of VanS-dependent vancomycin resistance requires binding of the drug to D-Ala-D-Ala termini in the peptidoglycan cell wall</article-title>. <source>Antimicrob. Agents. Chemother.</source>
<volume>57</volume>:<fpage>4470</fpage>&#x02013;<lpage>4480</lpage><pub-id pub-id-type="pmid">23836175</pub-id></mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chatterjee</surname><given-names>S.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Vijayakumar</surname><given-names>E.K.S.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Nadkarni</surname><given-names>S.R.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Patel</surname><given-names>M.V.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Blumbach</surname><given-names>J.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ganguli</surname><given-names>B.N.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Fehlhaber</surname><given-names>H.W.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kogler</surname><given-names>H.</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Vertesy</surname><given-names>L.</given-names></name></person-group>
<year>1994</year>
<article-title>Balhimycin, a New Glycopeptide Antibiotic with an unusual hydrated 3-amino-4-oxoaldopyranose sugar moiety</article-title>. <source>J. Org. Chem.</source>
<volume>59</volume>:<fpage>3480</fpage>&#x02013;<lpage>3484</lpage></mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nadkarni</surname><given-names>S.R.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Patel</surname><given-names>M.V.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Chatterjee</surname><given-names>S.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Vijayakumar</surname><given-names>E.K.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Desikan</surname><given-names>K.R.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Blumbach</surname><given-names>J.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ganguli</surname><given-names>B.N.</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Limbert</surname><given-names>M.</given-names></name></person-group>
<year>1994</year>
<article-title>Balhimycin, a new glycopeptide antibiotic produced by <italic>Amycolatopsis sp</italic>. Y-86,21022. Taxonomy, production, isolation and biological activity</article-title>. <source>J. Antibiot. (Tokyo).</source>
<volume>47</volume>:<fpage>334</fpage>&#x02013;<lpage>341</lpage><pub-id pub-id-type="pmid">8175486</pub-id></mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pelzer</surname><given-names>S.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sussmuth</surname><given-names>R.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Heckmann</surname><given-names>D.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Recktenwald</surname><given-names>J.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Huber</surname><given-names>P.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Jung</surname><given-names>G.</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Wohlleben</surname><given-names>W.</given-names></name></person-group>
<year>1999</year>
<article-title>Identification and analysis of the balhimycin biosynthetic gene cluster and its use for manipulating glycopeptide biosynthesis in <italic>Amycolatopsis mediterranei</italic> DSM5908</article-title>. <source>Antimicrob. Agents Chemother.</source>
<volume>43</volume>:<fpage>1565</fpage>&#x02013;<lpage>1573</lpage><pub-id pub-id-type="pmid">10390204</pub-id></mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shawky</surname><given-names>R.M.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Puk</surname><given-names>O.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wietuorrek</surname><given-names>A.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pelzer</surname><given-names>S.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Takano</surname><given-names>E.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wohlleben</surname><given-names>W.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Stegmann</surname><given-names>E.</given-names></name></person-group>
<year>2007</year>
<article-title>The border sequence of the balhimycin biosynthetic gene cluster from Amycolatopsis balhimicina contains bbr, encoding a StrR-like pathway-specific regulator</article-title>. <source>J. Mol. Microbiol. Biotechnol.</source>
<volume>13</volume>:<fpage>76</fpage>&#x02013;<lpage>88</lpage><pub-id pub-id-type="pmid">17693715</pub-id></mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sch&#x000e4;berle</surname><given-names>T.F.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Vollmer</surname><given-names>W.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Frasch</surname><given-names>H.J.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Huttel</surname><given-names>S.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kulik</surname><given-names>A.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Rottgen</surname><given-names>M.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>von Thaler</surname><given-names>A.K.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wohlleben</surname><given-names>W.</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Stegmann</surname><given-names>E.</given-names></name></person-group>
<year>2011</year>
<article-title>Self-resistance and cell wall composition in the glycopeptide producer <italic>Amycolatopsis balhimycina</italic></article-title>. <source>Antimicrob. Agents Chemother.</source>
<volume>55</volume>:<fpage>4283</fpage>&#x02013;<lpage>4289</lpage><pub-id pub-id-type="pmid">21690280</pub-id></mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bullock</surname><given-names>W.O.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Fernandez</surname><given-names>J.M.</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Short</surname><given-names>J.M.</given-names></name></person-group>
<year>1987</year>
<article-title>Xl1-Blue&#x02014;a high-efficiency plasmid transforming Reca <italic>Escherichia-Coli</italic> strain with beta-galactosidase selection</article-title>. <source>Biotechniques.</source>
<volume>5</volume>:<fpage>376</fpage>&#x02013;<lpage>378</lpage></mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacNeil</surname><given-names>D.J.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gewain</surname><given-names>K.M.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ruby</surname><given-names>C.L.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dezeny</surname><given-names>G.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gibbons</surname><given-names>P.H.</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>MacNeil</surname><given-names>T.</given-names></name></person-group>
<year>1992</year>
<article-title>Analysis of <italic>Streptomyces avermitilis</italic> genes required for avermectin biosynthesis utilizing a novel integration vector</article-title>. <source>Gene.</source>
<volume>111</volume>:<fpage>61</fpage>&#x02013;<lpage>68</lpage><pub-id pub-id-type="pmid">1547955</pub-id></mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Kieser</surname><given-names>T.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bibb</surname><given-names>M.J.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Buttner</surname><given-names>M.J.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Chater</surname><given-names>K.F.</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Hopwood</surname><given-names>D.A.</given-names></name></person-group>
<year>2000</year>
<article-title>Practical Streptomyces Genetics</article-title>: <publisher-name>John Innes Foundation, Norwich Research Park</publisher-name>, <publisher-loc>Colney, Norwich, United Kingdom</publisher-loc></mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menges</surname><given-names>R.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Muth</surname><given-names>G.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wohlleben</surname><given-names>W.</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Stegmann</surname><given-names>E.</given-names></name></person-group>
<year>2007</year>
<article-title>The ABC transporter Tba of <italic>Amycolatopsis balhimycina</italic> is required for efficient export of the glycopeptide antibiotic balhimycin</article-title>. <source>Appl. Microbiol. Biotechnol.</source>
<volume>77</volume>:<fpage>125</fpage>&#x02013;<lpage>134</lpage><pub-id pub-id-type="pmid">17823795</pub-id></mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pelzer</surname><given-names>S.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Reichert</surname><given-names>W.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Huppert</surname><given-names>M.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Heckmann</surname><given-names>D.</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Wohlleben</surname><given-names>W.</given-names></name></person-group>
<year>1997</year>
<article-title>Cloning and analysis of a peptide synthetase gene of the balhimycin producer <italic>Amycolatopsis mediterranei</italic> DSM5908 and development of a gene disruption/replacement system</article-title>. <source>J. Biotechnol.</source>
<volume>56</volume>:<fpage>115</fpage>&#x02013;<lpage>128</lpage><pub-id pub-id-type="pmid">9304873</pub-id></mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>S.N.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hunt</surname><given-names>H.D.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Horton</surname><given-names>R.M.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pullen</surname><given-names>J.K.</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Pease</surname><given-names>L.R.</given-names></name></person-group>
<year>1989</year>
<article-title>Site-directed mutagenesis by overlap extension using the polymerase chain reaction</article-title>. <source>Gene.</source>
<volume>77</volume>:<fpage>51</fpage>&#x02013;<lpage>59</lpage><pub-id pub-id-type="pmid">2744487</pub-id></mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flett</surname><given-names>F.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mersinias</surname><given-names>V.</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Smith</surname><given-names>C.P.</given-names></name></person-group>
<year>1997</year>
<article-title>High efficiency intergeneric conjugal transfer of plasmid DNA from <italic>Escherichia coli</italic> to methyl DNA-restricting streptomycetes</article-title>. <source>FEMS Microbiol. Lett.</source>
<volume>155</volume>:<fpage>223</fpage>&#x02013;<lpage>229</lpage><pub-id pub-id-type="pmid">9351205</pub-id></mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>S.N.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Chang</surname><given-names>A.C.</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Hsu</surname><given-names>L.</given-names></name></person-group>
<year>1972</year>
<article-title>Nonchromosomal antibiotic resistance in bacteria: genetic transformation of <italic>Escherichia coli</italic> by R-factor DNA</article-title>. <source>Proc. Natl. Acad. Sci. USA.</source>
<volume>69</volume>:<fpage>2110</fpage>&#x02013;<lpage>2114</lpage><pub-id pub-id-type="pmid">4559594</pub-id></mixed-citation></ref><ref id="B36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morrison</surname><given-names>D.A.</given-names></name></person-group>
<year>1979</year>
<article-title>Transformation and preservation of competent bacterial cells by freezing</article-title>. <source>Methods Enzymol.</source>
<volume>68</volume>:<fpage>326</fpage>&#x02013;<lpage>331</lpage><pub-id pub-id-type="pmid">396437</pub-id></mixed-citation></ref><ref id="B37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madon</surname><given-names>J.</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Hutter</surname><given-names>R.</given-names></name></person-group>
<year>1991</year>
<article-title>Transformation system for <italic>Amycolatopsis</italic> (<italic>Nocardia</italic>) mediterranei: direct transformation of mycelium with plasmid DNA</article-title>. <source>J. Bacteriol.</source>
<volume>173</volume>:<fpage>6325</fpage>&#x02013;<lpage>6331</lpage><pub-id pub-id-type="pmid">1655706</pub-id></mixed-citation></ref><ref id="B38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puk</surname><given-names>O.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bischoff</surname><given-names>D.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kittel</surname><given-names>C.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pelzer</surname><given-names>S.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Weist</surname><given-names>S.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Stegmann</surname><given-names>E.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sussmuth</surname><given-names>R.D.</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Wohlleben</surname><given-names>W.</given-names></name></person-group>
<year>2004</year>
<article-title>Biosynthesis of chloro-beta-hydroxytyrosine, a nonproteinogenic amino acid of the peptidic backbone of glycopeptide antibiotics</article-title>. <source>J. Bacteriol.</source>
<volume>186</volume>:<fpage>6093</fpage>&#x02013;<lpage>6100</lpage><pub-id pub-id-type="pmid">15342578</pub-id></mixed-citation></ref><ref id="B39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rice</surname><given-names>P.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Longden</surname><given-names>I.</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Bleasby</surname><given-names>A.</given-names></name></person-group>
<year>2000</year>
<article-title>EMBOSS: the European Molecular Biology Open Software Suite</article-title>. <source>Trends Genet. TIG.</source>
<volume>16</volume>:<fpage>276</fpage>&#x02013;<lpage>277</lpage><pub-id pub-id-type="pmid">10827456</pub-id></mixed-citation></ref><ref id="B40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frasch</surname><given-names>H.J.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kalan</surname><given-names>L.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kilian</surname><given-names>R.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Martin</surname><given-names>T.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wright</surname><given-names>G.</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Stegmann</surname><given-names>E.</given-names></name></person-group>
<year>2015</year>
<article-title>Alternative pathway to a glycopeptide-resistant cell wall in the balhimycin producer <italic>Amycolatopsis balhimycina</italic></article-title>. <source>ACS Infect. Dis.</source>
<volume>1</volume>:<fpage>243</fpage>&#x02013;<lpage>252</lpage><pub-id pub-id-type="pmid">27622740</pub-id></mixed-citation></ref><ref id="B41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burton</surname><given-names>K.</given-names></name></person-group>
<year>1956</year>
<article-title>A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid</article-title>. <source>Biochem. J.</source>
<volume>62</volume>:<fpage>315</fpage>&#x02013;<lpage>323</lpage><pub-id pub-id-type="pmid">13293190</pub-id></mixed-citation></ref><ref id="B42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novotna</surname><given-names>G.B.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kwun</surname><given-names>M.J.</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Hong</surname><given-names>H.J.</given-names></name></person-group>
<year>2015</year>
<article-title>In vivo characterization of the activation and interaction of the VanR-VanS two-component regulatory system controlling glycopeptide antibiotic resistance in two related <italic>Streptomyces</italic> species</article-title>. <source>Antimicrob. Agents Chemother.</source>
<volume>60</volume>:<fpage>1627</fpage>&#x02013;<lpage>1637</lpage><pub-id pub-id-type="pmid">26711760</pub-id></mixed-citation></ref><ref id="B43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishino</surname><given-names>K.</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Yamaguchi</surname><given-names>A.</given-names></name></person-group>
<year>2001</year>
<article-title>Overexpression of the response regulator EvgA of the two-component signal transduction system modulates multidrug resistance conferred by multidrug resistance transporters</article-title>. <source>J. Bacteriol.</source>
<volume>183</volume>:<fpage>1455</fpage>&#x02013;<lpage>1458</lpage><pub-id pub-id-type="pmid">11157960</pub-id></mixed-citation></ref><ref id="B44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>M.F.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lin</surname><given-names>Y.Y.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Yeh</surname><given-names>H.W.</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Lan</surname><given-names>C.Y.</given-names></name></person-group>
<year>2014</year>
<article-title>Role of the BaeSR two-component system in the regulation of <italic>Acinetobacter baumannii adeAB</italic> genes and its correlation with tigecycline susceptibility</article-title>. <source>BMC Microbiol.</source>
<volume>14</volume>:<fpage>119</fpage><pub-id pub-id-type="pmid">24885279</pub-id></mixed-citation></ref><ref id="B45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stegmann</surname><given-names>E.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Frasch</surname><given-names>H.J.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kilian</surname><given-names>R.</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Pozzi</surname><given-names>R.</given-names></name></person-group>
<year>2015</year>
<article-title>Self-resistance mechanisms of actinomycetes producing lipid II-targeting antibiotics</article-title>. <source>Int. J. Med. Microbiol.</source>
<volume>305</volume>:<fpage>190</fpage>&#x02013;<lpage>195</lpage><pub-id pub-id-type="pmid">25601631</pub-id></mixed-citation></ref><ref id="B46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wright</surname><given-names>G.D.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Molinas</surname><given-names>C.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Arthur</surname><given-names>M.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Courvalin</surname><given-names>P.</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Walsh</surname><given-names>C.T.</given-names></name></person-group>
<year>1992</year>
<article-title>Characterization of vanY, a DD-carboxypeptidase from vancomycin-resistant <italic>Enterococcus faecium</italic> BM4147</article-title>. <source>Antimicrob. Agents Chemother.</source>
<volume>36</volume>:<fpage>1514</fpage>&#x02013;<lpage>1518</lpage><pub-id pub-id-type="pmid">1510448</pub-id></mixed-citation></ref><ref id="B47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hugonnet</surname><given-names>J.E.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Haddache</surname><given-names>N.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Veckerle</surname><given-names>C.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dubost</surname><given-names>L.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Marie</surname><given-names>A.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Shikura</surname><given-names>N.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mainardi</surname><given-names>J.L.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Rice</surname><given-names>L.B.</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Arthur</surname><given-names>M.</given-names></name></person-group>
<year>2014</year>
<article-title>Peptidoglycan cross-linking in glycopeptide-resistant <italic>Actinomycetales</italic></article-title>. <source>Antimicrob. Agents Chemother.</source>
<volume>58</volume>:<fpage>1749</fpage>&#x02013;<lpage>1756</lpage><pub-id pub-id-type="pmid">24395229</pub-id></mixed-citation></ref><ref id="B48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marcone</surname><given-names>G.L.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Beltrametti</surname><given-names>F.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Binda</surname><given-names>E.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Carrano</surname><given-names>L.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Foulston</surname><given-names>L.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hesketh</surname><given-names>A.</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bibb</surname><given-names>M.</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Marinelli</surname><given-names>F.</given-names></name></person-group>
<year>2010</year>
<article-title>Novel mechanism of glycopeptide resistance in the A40926 producer <italic>Nonomuraea</italic> sp. ATCC 39727</article-title>. <source>Antimicrob. Agents Chemother.</source>
<volume>54</volume>:<fpage>2465</fpage>&#x02013;<lpage>2472</lpage><pub-id pub-id-type="pmid">20308385</pub-id></mixed-citation></ref></ref-list></back></article>